DEPT OF PHARMACOLOGY & PHARMACY



Researcher : Anand S

List of Research Outputs

Anand S., Tong H.Y.H., Besag F.M.C., Chan E.W., Cortese S. and Wong I.C.K., Safety, Tolerability And Efficacy Of Drugs For Treating Behavioural Insomnia In Children With Attention-deficit/hyperactivity Disorder: A Systematic Review With Methodological Quality Assessment. , Pediatr Drugs . 2017, 19(3): 235-250.
Chung A.Y., Anand S., Wong I.C.K., Tan K.C.B., Wong C.F., Chui C.M.W. and Chan E.W., Improving medication safety and diabetes management in Hong Kong: a multidisciplinary approach, Hong Kong Medical Journal. 2017, 23(2): 158-67.
Chung A.Y.S., Anand S., Wong I.C.K., Tan K.C.B., Wong F.F.C., Chui C.M.W. and Chan E.W., Improving medication safety and diabetes management in Hong Kong – A multi-disciplinary approach., Hong Kong Med. J. . 2017, 23(2): 158-167.
He Y.H., Wong I.C.K., Li X., Anand S., Leung W.K., Siu D.C.W. and Chan E.W., The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies, British Journal of Clinical Pharmacology. 2016, 82(1): 285-300.
WONG Y.S., Chan E.W., Anand S., Worsley A.J. and Wong I.C.K., Managing cardiovascular risk of macrolides: systematic review and meta-analysis. , Drug Saf . 2017.


Researcher : Baretella OM

List of Research Outputs

Baretella O.M., Chung S.K., Xu A. and Vanhoutte P.M.G.R., Endothelial overexpression of endothelin-1 modulates aortic, carotid, iliac and renal arterial responses in obese mice, Acta Pharmacologica Sinica. 2017, 38: 498-512.


Researcher : CAO H

List of Research Outputs

CAO H., Aggressive Breast Cancer Development in Adiponectin-deficient PyVT-MMTV Mice-Role of Thymus Dysfunction, 21st Research Postgraduate Symposium, December 1-2, 2016, Hong Kong. 2016.
LI D., CAO H., CHEN J. and Wang Y., Adiponectin-based Therapeutics in Cancer Treatment, Frontiers in Clinical Drug Research - Anti-Cancer Agents. Bentham Science, 2017, 4: 1-52.


Researcher : CHEN H

List of Research Outputs

CHEN H. and Leung S.W.S., AMPK Activator Inhibits EDH-like Relaxations in Superior Mesenteric Arteries of Rats, 12th International Symposium on Healthy Aging, 11-12 March 2017, Hong Kong. 2017.


Researcher : CHEN J

List of Research Outputs

CHEN J. and Woo W.H.C., Metabolic Function of TIR-Domain-containing Adaptor-inducing Interferon-b (TRIF) in Diet-induced obesity, The University of Hong Kong. 2016.
CHEN J., LI J., Xu A. and Woo W.H.C., Metabolic Function of TIR-Domain-containing adapter-inducing interferon-b (TRIF) in hepatocytes, In: Federation of American Societies for Experimental Biology, FASEB Science Research Conference: Immunological Aspects of Obesity. 2016.
CHEN J., Li J., Xu A. and Woo W.H.C., Metabolic function of TIR-domain-containing adapter-inducing interferon-b (TRIF) in hepatocytes, FASEB Science Research Conferences, July 31- August 5, 2016, Big Sky, Montana. 2016.
LI D., CAO H., CHEN J. and Wang Y., Adiponectin-based Therapeutics in Cancer Treatment, Frontiers in Clinical Drug Research - Anti-Cancer Agents. Bentham Science, 2017, 4: 1-52.


Researcher : CHEN J

List of Research Outputs

CHEN J. and Woo W.H.C., Metabolic Function of TIR-Domain-containing Adaptor-inducing Interferon-b (TRIF) in Diet-induced obesity, The University of Hong Kong. 2016.
CHEN J., LI J., Xu A. and Woo W.H.C., Metabolic Function of TIR-Domain-containing adapter-inducing interferon-b (TRIF) in hepatocytes, In: Federation of American Societies for Experimental Biology, FASEB Science Research Conference: Immunological Aspects of Obesity. 2016.
CHEN J., Li J., Xu A. and Woo W.H.C., Metabolic function of TIR-domain-containing adapter-inducing interferon-b (TRIF) in hepatocytes, FASEB Science Research Conferences, July 31- August 5, 2016, Big Sky, Montana. 2016.
LI D., CAO H., CHEN J. and Wang Y., Adiponectin-based Therapeutics in Cancer Treatment, Frontiers in Clinical Drug Research - Anti-Cancer Agents. Bentham Science, 2017, 4: 1-52.


Researcher : CHENG KF

List of Research Outputs

Cheung C.L., Ho D.K., SING C.W., TSOI M.F., CHENG K.F., LEE K.Y., Ho Y.N. and Cheung B.M.Y., Randomized controlled trial of the effect of phytosterols-enriched low-fat milk on lipid profile in Chinese, Scientific Reports. 2017, 7: 41084.
Wong H.Y., CHENG K.F., LEE K.Y. and Cheung C.L., Plenary Oral Presentation Award, Korean Endocrine Society. 2017.
Wong H.Y., CHENG K.F., LEE K.Y. and Cheung C.L., Precision Medicine of Denosumab Monotherapy in Osteoporotic Patients, The 5th Seoul International Congress of Endocrinology and Metabolism, SICEM 2017.


Researcher : CHEONG LY

List of Research Outputs

CHEONG L.Y., Absence of Inguinal Lymph Nodes Impairs the Browning of White Adipose Tissue, 21st Research Postgraduate Symposium, December 1-2, 2016, Hong Kong. 2016.
SHU L., Hoo R.L.C., WU X., PAN Y., LEE P.C., CHEONG L.Y., Bornstein S.R., Rong X., Gua J. and Xu A., A-FABP mediates adaptive thermogenesis by promoting intracellular activation of thyroid hormones in brown adipocytes., Nature Communications. 2017.
Shu L., WU X., PAN Y., CHEONG L.Y., Xu A. and Hoo R.L.C., Adipocyte fatty acid binding protein (A-FABP) modulates adaptive thermogenesis by enhancing intracellular activation of thyroid hormones in brown adipocytes, 2016 International Congress on Obesity and Metabolic Syndrome in conjunction with the 45th Annual Scientific Meeting of KSSO . 2016.
WU X., Shu L., CHEONG L.Y., Lam K.S.L., Xu A. and Hoo R.L.C., The role of adipocyte fatty acid binding protein (A-FABP) in the pathogenesis of liver fibrosis, FASEB Science Research Conference. 2017.


Researcher : CHEUNG C

List of Research Outputs

Li Z., Li S., Hu L., Li F., CHEUNG C., SHao W., Que Y., Leung G.P.H. and Yang C., MECHANISMS UNDERLYING ACTION OF XINMAILONG INJECTION, A TRADITIONAL CHINESE MEDICINE, IN CARDIAC FUNCTION IMPROVEMENT, African Journal of Traditional, Complementary and Alternative medicines. 2017, 14: 241-252.


Researcher : CHOW YT

List of Research Outputs

CHOW Y.T., Formulation of Small Nucleic Acids into Inhalable Dry Powders with Manitol and L-leucine Using Spray Drying Technology, 21st Research Postgraduate Symposium, December 1-2, 2016, Hong Kong. 2016.
CHOW Y.T., Lin H.H.S. and Lam J.K.W., Optimisation of inhalable spray dried powder formulation of small nucleic acids with mannitol and leucine, Drug Delivery to the Lungs 27. 2016.
QIU Y., CHOW Y.T. and Lam J.K.W., Synthetic KL4 peptide as new carrier of siRNA therapeutics for pulmonary delivery, Drug Delivery to the Lungs 27. 2016.


Researcher : CHUI SLC

List of Research Outputs

CHUI S.L.C., WONG Y.S., Lee H.M.E., Chang W.C., Chen E.Y.H., Wong I.C.K. and Chan E.W., Potential association between the use of oral fluoroquinolones and acute neuropsychiatric disorders in Hong Kong: a self-controlled case series study., ICPE, Dublin, Ireland, 25-28th August . 2016.
CHUI S.L.C., Wong I.C.K., WONG Y.S., LEE E.H.M., CHANG W.C., CHEN E.Y.H. and Chan E.W., The Association Between the Use of Oral Fluoroquinolones and Neuropsychiatric Events: A Self-Controlled Case Series Study, 32nd ICPE, Dublin, August 25-28, 2016.
WONG Y.S., Wong I.C.K., CHUI S.L.C., LEE E.H.M., CHANG W.C., CHEN E.Y.H., LEUNG W.K. and Chan E.W., Neuropsychiatric Events Associated with the Use of Helicobacter Pylori Eradication Therapy Containing-Clarithromycin: Self-Controlled Case Series, 32nd ICPE, Dublin, August 26-28, 2016.


Researcher : Cai Y

List of Research Outputs

PANG L., Cai Y., Tang E.H.C., YAN D., Li H., IRWIN M.G., MA H., Xia Z. and RAMOJI K., COX-2 inhibition protects against hypoxia/reoxygenation-induced cardiomyocyte apoptosis via Akt-dependent enhancentment of iNOS expression, Oxidative Medicine and Cellular Longevity. 2016.
YING F., Cai Y. and Tang E.H.C., Prostaglandin E receptor subtype 4 (EP4) regulates lipid droplet size and mitochondrial activity via FSP27 in white adipose tissue, Metabolic Diseases; Breakthrough Discoveries in Diabetes & Obesity, Novotel Melbourne St Kilda, 1-2 December 2016.
YING F., Cai Y., CAI Y., Wang Y. and Tang E.H.C., Prostaglandin E receptor subtype 4 regulates lipid droplet size and mitochondrial activity in murine subcutaneous white adipose tissue, The FASEB Journal. 2017, 331: 4023-4036.
YING F., Cai Y. and Tang E.H.C., Prostaglandin receptor subtype 4 (EP4) deficiency enhanced multilocular fat cell formation and mitochondrial biogenesis and facilated wat remodeling, The 6th ICCR Congress on Chronic Societal Cardiometabolic Diseases, May 15-17, 2017, Quebec Canada. 2017.


Researcher : Chan EW

Project Title:Intramuscular olanzapine versus haloperidol or midazolam for the management of acute agitation in the emergency department  a multicentre randomised clinical trial.
Investigator(s):Chan EW
Department:Pharmacology & Pharmacy
Source(s) of Funding:Early Career Scheme (ECS)
Start Date:01/2014


Project Title:Young adult patient experiences in clinical management of ADHD in Hong Kong
Investigator(s):Chan EW
Department:Pharmacology & Pharmacy
Source(s) of Funding:Janssen Pharmaceutica - General Award
Start Date:01/2014


Project Title:Mother’s preferences and willingness to pay for human papillomavirus vaccination for their daughters: a discrete choice experiment in Hong Kong
Investigator(s):Chan EW, McGhee S, Wong CKH, Ip DKM, Chau J, Wong ICK
Department:Pharmacology & Pharmacy
Source(s) of Funding:Health and Medical Research Fund - Full Grant
Start Date:05/2014
Completion Date:04/2017


Project Title:Oro-dispersible olanzapine (wafer) versus conventional oral haloperidol or diazepam tablets for the management of acute agitation in the Accident and Emergency Department - a multicentre randomised clinical trial.
Investigator(s):Chan EW, Leung LP
Department:Pharmacology & Pharmacy
Source(s) of Funding:General Research Fund (GRF)
Start Date:06/2016


Project Title:32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management; 1. #1289 - Hospitalization and Length of Stay Among Patients with Non-Valvular Atrial Fibrillation Taking Dabigatran or Warfarin: A Population-Based Cohort Study/2. #1023 - Dabigatran versus Warfarin in Patients with Non-Valvular Atrial Fibrillation: A Population-Wide Cohort Study in Chinese Patients
Investigator(s):Chan EW
Department:Pharmacology & Pharmacy
Source(s) of Funding:URC/CRCG - Conference Support for Teaching Staff
Start Date:08/2016
Completion Date:08/2016


Project Title:The prescribing trends and safety of biologics in Hong Kong
Investigator(s):Chan EW
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:06/2017


Project Title:Understanding drug abuser and their healthcare pathways: Towards better management in Hong Kong
Investigator(s):Chan EW, Tam AW
Department:Pharmacology & Pharmacy
Source(s) of Funding:Beat Drugs Fund Association
Start Date:06/2017


List of Research Outputs

Anand S., Tong H.Y.H., Besag F.M.C., Chan E.W., Cortese S. and Wong I.C.K., Safety, Tolerability And Efficacy Of Drugs For Treating Behavioural Insomnia In Children With Attention-deficit/hyperactivity Disorder: A Systematic Review With Methodological Quality Assessment. , Pediatr Drugs . 2017, 19(3): 235-250.
Botzenhardt S., Wong I.C.K., Chan E.W., SING C.W. and Neubert A., Safety profiles of iron chelators in young patients with haemoglobinopathies, Eur J Haematol . 2017, 98(3): 198-217.
CHUI S.L.C., WONG Y.S., Lee H.M.E., Chang W.C., Chen E.Y.H., Wong I.C.K. and Chan E.W., Potential association between the use of oral fluoroquinolones and acute neuropsychiatric disorders in Hong Kong: a self-controlled case series study., ICPE, Dublin, Ireland, 25-28th August . 2016.
CHUI S.L.C., Wong I.C.K., WONG Y.S., LEE E.H.M., CHANG W.C., CHEN E.Y.H. and Chan E.W., The Association Between the Use of Oral Fluoroquinolones and Neuropsychiatric Events: A Self-Controlled Case Series Study, 32nd ICPE, Dublin, August 25-28, 2016.
Chan E.W., Emergency Geriatrics, Central Commissioned Training Program (HA , A & E COC) Hong Kong. 2016.
Chan E.W., Evidence-based management of acute agitation., Central commissioned training program by COC (A&E), Kowloon, Hong Kong. 2017.
Chan E.W., LAU C.Y., Leung W.K., Michael M.T.C., Ying H., Tong S.M. and Wong I.C.K., Faculty Outstanding Research Output Award, Faculty of Medicine, The University of Hong Kong. 2016.
Chan E.W., Press Release, HKU discovers that traditional blood thinner drug is associated with a higher risk of osteoporotic fracture compared to newer drug, 研究指長期使用傳統薄血藥可致骨折 嚴重或增死亡率, 2017.
Chan E.W., The management of acute agitation in the emergency setting., EMCORE Masterclass Hong Kong. 2017.
Chan P.H.M., Hai S.H.J.J., Huang D., Ho M.H., Chan E.W., Cheung B.M.Y., Wong I.C.K., Tse H.F., Hung F.N.I. and Siu D.C.W., Burden of upper gastrointestinal symptoms in patients prescribed Dabigatran for stroke prevention., Sage Open Medicine . 2016, 4:2050312116662414.
Chung A.Y., Anand S., Wong I.C.K., Tan K.C.B., Wong C.F., Chui C.M.W. and Chan E.W., Improving medication safety and diabetes management in Hong Kong: a multidisciplinary approach, Hong Kong Medical Journal. 2017, 23(2): 158-67.
Chung A.Y.S., Anand S., Wong I.C.K., Tan K.C.B., Wong F.F.C., Chui C.M.W. and Chan E.W., Improving medication safety and diabetes management in Hong Kong – A multi-disciplinary approach., Hong Kong Med. J. . 2017, 23(2): 158-167.
He Y.H., Wong I.C.K., Li X., Anand S., Leung W.K., Siu D.C.W. and Chan E.W., The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies, British Journal of Clinical Pharmacology. 2016, 82(1): 285-300.
LAO S., Chan E.W., Man K.C.K. and Wong I.C.K., Antipsychotic Prescription Trend in Hong Kong from 2004 to 2014, 32nd ICPE, Dublin, August 25-28, 2016.
LAO S., Tam A.W., Wong I.C.K., Besag F.M.C., Man K.C.K., Chui S.L.C. and Chan E.W., Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groups, Pharmacoepidemiology and Drug Safety. 2017.
LAO S., He Y., Wong I.C.K., Besag F.M.C. and Chan E.W., Tolerability and safety profile of cariprazine in treating psychotic disorder, bipolar disorder and major depressive disorder: a systematic review with meta-analysis of randomised controlled trials., CNS Drugs. 2016, 30(11): 1043-1054.
LAO S., HE Y., Wong I.C.K., BESAG F.M.C. and Chan E.W., Tolerability/Safety Profile of Cariprazine in Treating Psychotic Disorders/Bipolar Disorder: A Systematic Review with Meta-Analysis of RCTs , 32nd ICPE, Dublin, August 25-28, 2016.
LAU C.Y., Chan E.W., Cheung C.L., SING C.W., Man K.C.K., Lip G.Y.H., Siu D.C.W., Lam K.Y.J., Lee C.H.A. and Wong I.C.K., Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation, JAMA. 2017, 317: 1151.
LAU C.Y., Li X., Wong I.C.K. and Chan E.W., Bleeding-related hospital admissions and 30-day readmission with dabigatran versus warfarin in patients with non-valvular atrial fibrillation, ISPOR, Boston USA, 20-24th May (Poster) 2017.
LAU C.Y., Chan E.W. and Wong I.C.K., Dabigatran versus Warfarin in Patients with Non-Valvular Atrial Fibrillation: A Population-Wide Cohort Study in Chinese Patients. , ICPE, Dublin, Ireland, 25-28th August.. 2016.
LAU C.Y., Li X., Wong I.C.K. and Chan E.W., Hospitalization and Length of Stay among Patients with Non-Valvular Atrial Fibrillation Taking Dabigatran or Warfarin: A Population-Based Cohort Study., ICPE, Dublin, Ireland, 25-28th August . 2016.
Leung W.K., Chan E.W., Wong Y.S., Chen L., Wong O.L., Wong I.C. and Cheung M.K.S., Age of Helicobacter pylori Eradication and Subsequent Risk of Gastric Cancer Development: A Population-Based Study, Digestive Disease Week, 6-9 May 2017, Chicago, USA. 2017.
Li W., Huang D., Chiang C.E., Lau C.P., Tse H.F., Chan E.W., Wong I.C.K., Lip G., Chan P.H.M. and Siu D.C.W., Efficacy and Safety of Dabigatran, Rivaroxaban and Warfarin for Stroke Prevention in patients with Atrial Fibrillation: The Hong Kong Atrial Fibrillation Project, Clin Cardiol. 2017, 40(4): 222-229.
Li X., Chan N.S., Tam A.W., Hung F.N.I. and Chan E.W., Budget impact and cost-effectiveness analyses of direct-acting antivirals for chronic hepatitis C virus infection in Hong Kong, European Journal of Clinical Microbiology & Infectious Diseases. 2017.
Li X., Chan S.N., Tam A.W. and Chan E.W., Budget impact and cost-effectiveness analyses of newly available treatments for chronic hepatitis C infection in Hong Kong,, ISPOR 22nd Annual International Meeting 2017.
Li X., Au-Doung L.W. and Chan E.W., The Impact Of Ischemic Stroke On Atrial Fibrillation-related Healthcare Cost: A Systematic Review, ISPOR 7th Asia-Pacific Conference, 3-6th September (Poster). 2016.
Man K.C.K., Coghill D., Chan E.W., LAU C.Y., Hollis C., Liddle E., Banaschewski T., McCarthy S., Neubert A., Sayal K., Ip P. and Wong I.C.K., Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system, Translational Psychiatry. Nature Publishing Group, 2016, 6(11): e956.
Man K.C.K., Chan E.W., Ip P., Coghill D.R., Simonoff E., Chan P.K.L., LAU C.Y., Schuemie M.J., Sturkenboom M.C.J.M. and Wong I.C.K., Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study, BMJ. 2017, j2350.
Man K.C.K., Li X., Chan E.W. and Wong I.C.K., The Long term use of biologics in Hong Kong., ICPE, Dublin, Ireland, 25-28th August. 2016.
Roughead E.E., Chan E.W., Choi N.K., Griffiths J., Lee J., Kimura T., Kubota K., Lai E.C., Man K.C.K., Nguyen T.A., Ooba N., Park B.J., Sato T., Shin J.Y., Wang T.T., Wong I.C.K., Kao Yang Y.H. and Pratt N., Proton pump inhibitors and risk of Clostridium difficile infection: a multi-country study using sequence symmetry analysis., Expert Opinion On Drug Safety. 2016, 15(12): 1589-1595.
Taylor D.M., Yap C., Knott J.C., Taylor S.E., Phillips G.A., Karro J., Chan E.W., Kong D.C.M. and Castle D.J., Midazolam-droperidol, droperidol or olanzapine for acute agitation: a randomised clinical trial, Ann Emerg Med. 2017, 69(3): 318-326.e1.
Taylor D.M.C.D., Yap C., Knott J.C., Taylor S.E., Philips G.A., Karro J., Chan E.W., Castle D.C. and Kong D.C.M., Sedating the agitated patient: a moving target? – In reply., Ann Emerg Med. 2017, 69(4): 521-523.
WONG Y.S., Chan E.W., Anand S., Worsley A.J. and Wong I.C.K., Managing cardiovascular risk of macrolides: systematic review and meta-analysis. , Drug Saf . 2017.
WONG Y.S., Wong I.C.K., CHUI S.L.C., LEE E.H.M., CHANG W.C., CHEN E.Y.H., LEUNG W.K. and Chan E.W., Neuropsychiatric Events Associated with the Use of Helicobacter Pylori Eradication Therapy Containing-Clarithromycin: Self-Controlled Case Series, 32nd ICPE, Dublin, August 26-28, 2016.
Yap C., Taylor D.M.C.D., Knott J.C., Taylor S.E., Phillips G.A., Karro J., Chan E.W., Kong D.C.M. and Castle D.C., Intravenous Midazolam-Droperidol Combination, Droperidol or Olanzapine Monotherapy for Methamphetamine-related Acute Agitation: A Subgroup Analysis of a Randomised Controlled Trial, Addiction. 2017.


Researcher : Chan WLP

List of Research Outputs

Chan L.K., Wong F.K.Y., Ganotice F.J.A., Lau W.C.S., Lam T.P., Bridges S.M., Chan N.K., Chan W.L.P., Chen H., Chen J.Y., Chu K.P.J., Ho C.C., Ho J.M.C., Chin W.Y., Harbutt D., Khoo U.S., Lam S.F., Lao L., Leung G.K.K. and Li Q., Bronze in Discipline Award (Life Sciences), in Quacquarelli Symonds (QS) Reimagine Education competition: Interprofessional Team-Based Learning for Health Professional Students, Quacquarelli Symonds. 2016.


Researcher : Chan WYE

Project Title:Intramuscular olanzapine versus haloperidol or midazolam for the management of acute agitation in the emergency department  a multicentre randomised clinical trial.
Investigator(s):Chan EW
Department:Pharmacology & Pharmacy
Source(s) of Funding:Early Career Scheme (ECS)
Start Date:01/2014


Project Title:Young adult patient experiences in clinical management of ADHD in Hong Kong
Investigator(s):Chan EW
Department:Pharmacology & Pharmacy
Source(s) of Funding:Janssen Pharmaceutica - General Award
Start Date:01/2014


Project Title:Mother’s preferences and willingness to pay for human papillomavirus vaccination for their daughters: a discrete choice experiment in Hong Kong
Investigator(s):Chan EW, McGhee S, Wong CKH, Ip DKM, Chau J, Wong ICK
Department:Pharmacology & Pharmacy
Source(s) of Funding:Health and Medical Research Fund - Full Grant
Start Date:05/2014
Completion Date:04/2017


Project Title:Oro-dispersible olanzapine (wafer) versus conventional oral haloperidol or diazepam tablets for the management of acute agitation in the Accident and Emergency Department - a multicentre randomised clinical trial.
Investigator(s):Chan EW, Leung LP
Department:Pharmacology & Pharmacy
Source(s) of Funding:General Research Fund (GRF)
Start Date:06/2016


Project Title:32nd International Conference on Pharmacoepidemiology & Therapeutic Risk Management; 1. #1289 - Hospitalization and Length of Stay Among Patients with Non-Valvular Atrial Fibrillation Taking Dabigatran or Warfarin: A Population-Based Cohort Study/2. #1023 - Dabigatran versus Warfarin in Patients with Non-Valvular Atrial Fibrillation: A Population-Wide Cohort Study in Chinese Patients
Investigator(s):Chan EW
Department:Pharmacology & Pharmacy
Source(s) of Funding:URC/CRCG - Conference Support for Teaching Staff
Start Date:08/2016
Completion Date:08/2016


Project Title:The prescribing trends and safety of biologics in Hong Kong
Investigator(s):Chan EW
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:06/2017


Project Title:Understanding drug abuser and their healthcare pathways: Towards better management in Hong Kong
Investigator(s):Chan EW, Tam AW
Department:Pharmacology & Pharmacy
Source(s) of Funding:Beat Drugs Fund Association
Start Date:06/2017


List of Research Outputs



Researcher : Cheung CL

Project Title:Genetics and genomics of anti-thyroid drug induced agranulocytosis
Investigator(s):Cheung CL, Kung AWC, Tan KCB, Sham PC, Wong ICK
Department:Medicine
Source(s) of Funding:General Research Fund (GRF)
Start Date:01/2015


Project Title:The role of Vitamin D and bone metabolism in cardiovascular events risk, an interaction or mediation? An 11 year follow-up study
Investigator(s):Cheung CL, Tan KCB, Kung AWC, Cheung BMY
Department:Pharmacology & Pharmacy
Source(s) of Funding:Health and Medical Research Fund - Full Grant
Start Date:02/2015


Project Title:Pharmacogenomics Assessment of Serious Cutaneous Adverse drug reactions (PASCA): A retrospective study
Investigator(s):Cheung CL, Chan CYJ, Sham PC, Cheung BMY, Wong ICK
Department:Pharmacology & Pharmacy
Source(s) of Funding:Health and Medical Research Fund - Full Grant
Start Date:04/2015


Project Title:Precision Medicine of Osteoporosis Medication in Chinese (PreMOMiC): A retrospective and prospective pharmacogenomic study of denosumab
Investigator(s):Cheung CL
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:06/2016
Completion Date:05/2017


Project Title:Metabolomic Study of Osteoporosis in Southern Chinese
Investigator(s):Cheung CL
Department:Pharmacology & Pharmacy
Source(s) of Funding:Early Career Scheme (ECS)
Start Date:09/2016


Project Title:Identification of susceptibility genes involved in the pathogenesis and prediction of thyrotoxic periodic paralysis
Investigator(s):Cheung CL
Department:Pharmacology & Pharmacy
Source(s) of Funding:NSFC/RGC Joint Research Scheme
Start Date:01/2017


Project Title:Genetic screening service of HLA-B*38:02 in people prescribing antithyroid drug
Investigator(s):Cheung CL, Tan KCB, Cheung BMY
Department:Pharmacology & Pharmacy
Source(s) of Funding:S.K. Yee Medical Foundation - General Award
Start Date:03/2017


Project Title:The 44th European Calcified Tissue Society (ECTS) Congress 2017; Early anti-osteoporosis treatment and risk of cardiovascular mortality after hip fracture: A population based study
Investigator(s):Cheung CL
Department:Pharmacology & Pharmacy
Source(s) of Funding:URC/CRCG - Conference Support for Teaching Staff
Start Date:05/2017
Completion Date:05/2017


List of Research Outputs

Cheung B.M.Y., Tam F.C.C., Cheung C.L., Chan E.Y.T., Tsui M.S.H. and Lee S.W.L., Beta-2 microglobulin level in serum is elevated in patients presenting with acute coronary syndrome., Presented at the Great Wall International Congress of Cardiology, Beijing 2016.. 2016.
Cheung B.M.Y., tam F., Cheung C.L., Lee S.W.L., Tsui M.S.H. and Chan E., Serum beta-2 microglobulin level is elevated in patients with acute coronary syndrome., Presented at the 13th Congress of the European Association for Clinical Pharmacology and Therapeutics, Prague, 2017.. 2017.
Cheung B.M.Y., Tam F.C.C., Cheung C.L., Lee S.W.L., Tsui M.S.H. and Chan E.Y.T., Serum beta-2 microglobulin level is elevated in patients with acute coronary syndrome., Presented at the 5th Seoul International Congress of Endocrinology and Metabolism 2017.. 2017.
Cheung C.L., Leung Y.H., Cheung B.M.Y., Nguyen U.S., Kung A.W.C. and Tan K.C.B., Optimal vitamin D status and its relationship with bone and mineral metabolism in Hong Kong Chinese., American Society for Bone and Mineral Research Annual Meeting, Atlanta, Sept 2016.. 2016.
Cheung C.L., Ho D.K., SING C.W., TSOI M.F., CHENG K.F., LEE K.Y., Ho Y.N. and Cheung B.M.Y., Randomized controlled trial of the effect of phytosterols-enriched low-fat milk on lipid profile in Chinese, Scientific Reports. 2017, 7: 41084.
Cheung C.L. and Tan K.C.B., Serum 25-hydroxyvitamin D and the risk of stroke in Hong Kong Chinese., Thromb Haemost.. 2017, 117(1): 158-163.
Chow K.L., Tse K.Y., Cheung C.L., Wong K.W., Cheung A.N.Y., Wong W.C., Chan A.N.H., Yuen N.W.F., Ngan H.Y.S. and Ip P.C.P., The mitosis-specific marker phosphohistone-H3 (PHH3) is an independent prognosticator in uterine smooth muscle tumours: an outcome-based study, Histopathology. United Kingdom, Wiley, 2017, 70: 746-755.
LAU C.Y., Chan E.W., Cheung C.L., SING C.W., Man K.C.K., Lip G.Y.H., Siu D.C.W., Lam K.Y.J., Lee C.H.A. and Wong I.C.K., Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation, JAMA. 2017, 317: 1151.
LEUNG Y.H., Cheung B.M.Y., Nguyen U.S., Kung A.W.C., Tan K.C.B. and Cheung C.L., Optimal vitamin D status and its relationship with bone and mineral metabolism in Hong Kong Chinese, Bone. 2017, 97: 293-298.
Lee C.H.A., Chan P.H.M., Cheung C.L., Siu D.C.W., Leung Y.H., Wong T.W., Pang H.K. and Tan K.C.B., Diagnostic performance of different clinical criteria for familial hypercholesterolemia in Hong Kong Chinese patients. , 33rd Annual Scientific Meeting of the Hong Kong Society of Endocrinology, Metabolism and Reproduction, Hong Kong Nov 2016.. 2016.
Leung Y.H., Cheung B.M.Y., Wong I.C.K., Tan K.C.B., Kung A.W.C. and Cheung C.L., 25-hydroxyvitamin D and the risk of incident diabetes in Hong Kong Chinese., Presented at the 13th Congress of the European Association for Clinical Pharmacology and Therapeutics, Prague, 2017.. 2017.
Leung Y.H., Cheung B.M.Y., Wong I.C.K., Tan K.C.B., Kung A.W.C. and Cheung C.L., 25-hydroxyvitamin D and the risk of incident diabetes in Hong Kong Chinese., Presented at the 5th Seoul International Congress of Endocrinology and Metabolism 2017.. 2017.
Leung Y.H., Han Y., SING C.W., Cheung B.M.Y., Wong I.C.K., Tan K.C.B., Kung A.W.C. and Cheung C.L., Serum 25-hydroxyvitamin D and the risk of stroke in Hong Kong Chinese., Presented at the 20th Anniversary Scientific Meeting of the Institute of Cardiovascular Science and Medicine, 2016.. 2016.
Leung Y.H., Han Y., SING C.W., Cheung B.M.Y., Wong I.C.K., Tan K.C.B., Kung A.W.C. and Cheung C.L., Serum 25-hydroxyvitamin D and the risk of stroke in Hong Kong Chinese, Thrombosis and Haemostasis. 2016, 117: 158-163.
SING C.W. and Cheung C.L., Early Anti-Osteoporosis Treatment and Risk of Mortality After Hip Fracture: A Population Based Study, WCO-IOF-ESCEO Florence 2107, March 23-26, 2017, Florence Italy. 2017.
SING C.W., Wong I.C.K., Cheung B.M.Y., Chan C.Y.J., Chu K.P.J. and Cheung C.L., Incidence and risk estimate of drug-induced agranulocytosis in Hong Kong Chinese. A population-based case-control study, Pharmacoepidemiology and Drug Safety. 2017, 26: 248-255.
TSOI M.F., Cheung T.T., Lam M.P.S. and Cheung C.L., Safety of colchicine for gout: a ten-year survey of the Hong Kong population., Presented at the 13th Congress of the European Association for Clinical Pharmacology and Therapeutics, Prague, 2017.. 2017.
Wong H.Y., LEE K.Y. and Cheung C.L., Metabolomics of Sarcopenia in Hong Kong Chinese, The 18th Regional Osteoporosis Conference. Hong Kong. 2017.
Wong H.Y., CHENG K.F., LEE K.Y. and Cheung C.L., Plenary Oral Presentation Award, Korean Endocrine Society. 2017.
Wong H.Y., CHENG K.F., LEE K.Y. and Cheung C.L., Precision Medicine of Denosumab Monotherapy in Osteoporotic Patients, The 5th Seoul International Congress of Endocrinology and Metabolism, SICEM 2017.


Researcher : Cho CH

Project Title:Advances in GI Pharmacology - From Acid Secretion to Mucosal Protection Symposium Non-ulcerogenic Dose of Dexamethasone Delays Gastric Ulcer Healing in Rats
Investigator(s):Cho CH
Department:Pharmacology & Pharmacy
Source(s) of Funding:URC/CRCG - Conference Support for Teaching Staff
Start Date:11/2004


Project Title:Adrenaline and its receptor activation on colon cancer growth
Investigator(s):Cho CH
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:02/2006




Researcher : Chu KPJ

List of Research Outputs

Chan L.K., Wong F.K.Y., Ganotice F.J.A., Lau W.C.S., Lam T.P., Bridges S.M., Chan N.K., Chan W.L.P., Chen H., Chen J.Y., Chu K.P.J., Ho C.C., Ho J.M.C., Chin W.Y., Harbutt D., Khoo U.S., Lam S.F., Lao L., Leung G.K.K. and Li Q., Bronze in Discipline Award (Life Sciences), in Quacquarelli Symonds (QS) Reimagine Education competition: Interprofessional Team-Based Learning for Health Professional Students, Quacquarelli Symonds. 2016.
Chan P.T.Y. and Chu K.P.J., A Drug Use Evaluation of Amoxicillin/Clavulanate in Hospital Setting: a Focus on Prescribing Patterns, Hong Kong Pharmaceutical Journal . 2017, 24(1): 11-17.
Chu K.P.J., University Early Career Teaching Award, University of Hong Kong . 2016.
Mak C.Y. and Chu K.P.J., Antibiotic Stewardship Programme: Focusing on Ciprofloxacin , Hong Kong Pharmaceutical Journal . 2016, 23 (4): 127-131.
SING C.W., Wong I.C.K., Cheung B.M.Y., Chan C.Y.J., Chu K.P.J. and Cheung C.L., Incidence and risk estimate of drug-induced agranulocytosis in Hong Kong Chinese. A population-based case-control study, Pharmacoepidemiology and Drug Safety. 2017, 26: 248-255.


Researcher : Chui CMW

List of Research Outputs

Chung A.Y., Anand S., Wong I.C.K., Tan K.C.B., Wong C.F., Chui C.M.W. and Chan E.W., Improving medication safety and diabetes management in Hong Kong: a multidisciplinary approach, Hong Kong Medical Journal. 2017, 23(2): 158-67.
Chung A.Y.S., Anand S., Wong I.C.K., Tan K.C.B., Wong F.F.C., Chui C.M.W. and Chan E.W., Improving medication safety and diabetes management in Hong Kong – A multi-disciplinary approach., Hong Kong Med. J. . 2017, 23(2): 158-167.


Researcher : DETREMMERIE CMS

List of Research Outputs

DETREMMERIE C.M.S., CHEN Z., LI Z., ALKHARFY K.M., Leung S.W.S., Xu A., GAO Y. and Vanhoutte P.M.G.R., Endothelium-Dependent Contractions of Isolated Arteries to Thymoquinone Require Biased Activity of Soluble Guanylyl Cyclase with Subsequent Cyclic IMP Production, Journal of Pharmacology and Experimental Therapeutics. 2016, 358: 558-568.
DETREMMERIE C.M.S., Leung S.W.S., Xu A., Gao Y.S. and Vanhoutte P.M.G.R., Mechanisms of Vasodilatation 12th International Symposium. November 6-9, 2016, Rochester, Minn., USA: Abstracts, Journal of Vascular Research. 2016, 53: 1-70.


Researcher : Deng H

List of Research Outputs

YANG K., Deng H., MAN W.C., SONG E., Zhang J., Luo C., Cheung B.M.Y., Yuen K.Y., Jensen P.S., Irmukhamedov A., Elie A...G...I...M., Vanhoutte P.M.G.R., Xu A., De Mey J.G.R. and Wang Y., Measuring non-polyaminated lipocalin-2 for cardiometabolic risk assessment, ESC Heart Failure. 2017, 1-13.


Researcher : Dufay S

Project Title:Quantitation of Dexmedetomidine in plasma for pharmacokinetic study after intranasal administration in healthy volunteers
Investigator(s):Dufay S, Irwin MG, Wong ICK
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:06/2013




Researcher : FENG T

List of Research Outputs

FENG T., The Role of Lactate in Macrophage Polaization and Adipose Tissue Inflammation, 21st Research Postgraduate Symposium, December 1-2, 2016, Hong Kong. 2016.


Researcher : Guo Y

List of Research Outputs

LUO D., Huang M., Guo Y., Li D., CHENG Y., Zhao J., Wang Y. and Rong J., Plant-derived triterpenoid celastrol ameliorates inflammation and metabolic dysfunctions in adipose tissues via covalent modification of ER chaperone GRP78/BiP, Keystone Symposia: Neuronal Control of Appetite, Metabolism and Weight. 9–13 May 2017, København V, Denmark. 2017.


Researcher : HE Y

List of Research Outputs

LAO S., HE Y., Wong I.C.K., BESAG F.M.C. and Chan E.W., Tolerability/Safety Profile of Cariprazine in Treating Psychotic Disorders/Bipolar Disorder: A Systematic Review with Meta-Analysis of RCTs , 32nd ICPE, Dublin, August 25-28, 2016.


Researcher : He YH

List of Research Outputs

He Y.H., Wong I.C.K., Li X., Anand S., Leung W.K., Siu D.C.W. and Chan E.W., The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies, British Journal of Clinical Pharmacology. 2016, 82(1): 285-300.


Researcher : Hoo RLC

Project Title:The inter-relationship between A-FABF, endoplasmic reticulum stress and autophagy in the pathogenesis of obesity-induced imflammation
Investigator(s):Hoo RLC, Zhang J
Department:Medicine
Source(s) of Funding:National Natural Science Foundation of China (NSFC) - General Program
Start Date:01/2013


Project Title:Adipocyte fatty acid binding protein (A-FABP) as a potential mediator of cardiac dysfunction and heart failure related to diabetes and obesity
Investigator(s):Hoo RLC, Xia Z, Xu A
Department:Medicine
Source(s) of Funding:General Research Fund (GRF)
Start Date:01/2014
Completion Date:01/2018


Project Title:Deciphering the role of lipid chaperone fatty acid binding protein 4 in the development of obesity-induced diabetic nephropathy
Investigator(s):Hoo RLC, Xu A
Department:Medicine
Source(s) of Funding:Seed Fund for Basic Research
Start Date:04/2015
Completion Date:03/2017


Project Title:Adipocyte fatty acid binding protein (A-FABP) is a potential therapeutic target of both alcoholic and non-alcoholic steatohepatitis
Investigator(s):Hoo RLC, Xu A
Department:Medicine
Source(s) of Funding:Health and Medical Research Fund - Full Grant
Start Date:04/2015


Project Title:The role of adipocyte fatty acid binding protein (A-FABP) in the pathogenesis of ischemic stroke associating with obesity
Investigator(s):Hoo RLC, Xu A
Department:Medicine
Source(s) of Funding:Seed Fund for Basic Research
Start Date:04/2016


Project Title:Adipocyte fatty acid binding protein (A-FABP) is a pathological mediator of obesity-related renal dysfunction.
Investigator(s):Hoo RLC, Xu A
Department:Medicine
Source(s) of Funding:Health and Medical Research Fund - Full Grant
Start Date:06/2016


Project Title:2016 International Congress on Obesity and Metabolic Syndrome in conjunction with the 45th Annual Scientific Meeting of KSSO; Adipocyte Fatty Acid Binding Protein (A-FABP) Modulates Adaptive Thermogenesis by Promoting Intracellular Activation of Thyroid Hormones in Brown Adipocytes
Investigator(s):Hoo RLC
Department:Medicine
Source(s) of Funding:URC/CRCG - Conference Support for Teaching Staff
Start Date:09/2016
Completion Date:09/2016


Project Title:The role of lipid chaperone ap2 in regional adipose tissue expandability
Investigator(s):Hoo RLC, Xu A
Department:Medicine
Source(s) of Funding:Seed Fund for Basic Research
Start Date:04/2017


List of Research Outputs

Shu L., WU X., PAN Y., CHEONG L.Y., Xu A. and Hoo R.L.C., Adipocyte fatty acid binding protein (A-FABP) modulates adaptive thermogenesis by enhancing intracellular activation of thyroid hormones in brown adipocytes, 2016 International Congress on Obesity and Metabolic Syndrome in conjunction with the 45th Annual Scientific Meeting of KSSO . 2016.


Researcher : Huang M

List of Research Outputs

LUO D., Huang M., Guo Y., Li D., CHENG Y., Zhao J., Wang Y. and Rong J., Plant-derived triterpenoid celastrol ameliorates inflammation and metabolic dysfunctions in adipose tissues via covalent modification of ER chaperone GRP78/BiP, Keystone Symposia: Neuronal Control of Appetite, Metabolism and Weight. 9–13 May 2017, København V, Denmark. 2017.


Researcher : JIN L

List of Research Outputs

GENG L., LIAO B., JIN L., HUANG Z., Woo W.H.C., Lam K.S.L. and Xu A., Chronic exercise alleviated dietary obesity-associated metabolic dysfunction by enhancing FGF-21 sensitivity in adipose tissues., The 99th Annual Meeting of the American Endocrine Society, 1-4 April 2017, Orlando, USA. 2017.


Researcher : Kwok PCL

Project Title:Inhalable antimicrobial peptide dry powder for tuberculosis treatment
Investigator(s):Kwok PCL, Lam JKW
Department:Pharmacology & Pharmacy
Source(s) of Funding:Small Project Funding
Start Date:04/2014
Completion Date:06/2017


Project Title:Aerosol performance of generic pharmaceutical combination inhalers
Investigator(s):Kwok PCL
Department:Pharmacology & Pharmacy
Source(s) of Funding:Small Project Funding
Start Date:04/2015
Completion Date:07/2017


Project Title:Dexmedetomidine buccal spray solution for premedication in children
Investigator(s):Kwok PCL, Dufay S, Yuen VMY
Department:Pharmacology & Pharmacy
Source(s) of Funding:Health and Medical Research Fund - Mini Grant
Start Date:05/2015


Project Title:Transport of dexmedetomidine across the nasal mucosa
Investigator(s):Kwok PCL
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:06/2016
Completion Date:07/2017


Project Title:Drug Delivery to the Lungs 27; Droplet Sizes of Electronic Cigarette Aerosols
Investigator(s):Kwok PCL
Department:Pharmacology & Pharmacy
Source(s) of Funding:URC/CRCG - Conference Support for Teaching Staff
Start Date:12/2016
Completion Date:12/2016




Researcher : LAO S

List of Research Outputs

LAO S., Chan E.W., Man K.C.K. and Wong I.C.K., Antipsychotic Prescription Trend in Hong Kong from 2004 to 2014, 32nd ICPE, Dublin, August 25-28, 2016.
LAO S., Tam A.W., Wong I.C.K., Besag F.M.C., Man K.C.K., Chui S.L.C. and Chan E.W., Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groups, Pharmacoepidemiology and Drug Safety. 2017.
LAO S., He Y., Wong I.C.K., Besag F.M.C. and Chan E.W., Tolerability and safety profile of cariprazine in treating psychotic disorder, bipolar disorder and major depressive disorder: a systematic review with meta-analysis of randomised controlled trials., CNS Drugs. 2016, 30(11): 1043-1054.
LAO S., HE Y., Wong I.C.K., BESAG F.M.C. and Chan E.W., Tolerability/Safety Profile of Cariprazine in Treating Psychotic Disorders/Bipolar Disorder: A Systematic Review with Meta-Analysis of RCTs , 32nd ICPE, Dublin, August 25-28, 2016.


Researcher : LAU CY

List of Research Outputs

Chan E.W., LAU C.Y., Leung W.K., Michael M.T.C., Ying H., Tong S.M. and Wong I.C.K., Faculty Outstanding Research Output Award, Faculty of Medicine, The University of Hong Kong. 2016.
LAU C.Y., Chan E.W., Cheung C.L., SING C.W., Man K.C.K., Lip G.Y.H., Siu D.C.W., Lam K.Y.J., Lee C.H.A. and Wong I.C.K., Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation, JAMA. 2017, 317: 1151.
LAU C.Y., Li X., Wong I.C.K. and Chan E.W., Bleeding-related hospital admissions and 30-day readmission with dabigatran versus warfarin in patients with non-valvular atrial fibrillation, ISPOR, Boston USA, 20-24th May (Poster) 2017.
LAU C.Y., Chan E.W. and Wong I.C.K., Dabigatran versus Warfarin in Patients with Non-Valvular Atrial Fibrillation: A Population-Wide Cohort Study in Chinese Patients. , ICPE, Dublin, Ireland, 25-28th August.. 2016.
LAU C.Y., Li X., Wong I.C.K. and Chan E.W., Hospitalization and Length of Stay among Patients with Non-Valvular Atrial Fibrillation Taking Dabigatran or Warfarin: A Population-Based Cohort Study., ICPE, Dublin, Ireland, 25-28th August . 2016.
Man K.C.K., Coghill D., Chan E.W., LAU C.Y., Hollis C., Liddle E., Banaschewski T., McCarthy S., Neubert A., Sayal K., Ip P. and Wong I.C.K., Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system, Translational Psychiatry. Nature Publishing Group, 2016, 6(11): e956.
Man K.C.K., Chan E.W., Ip P., Coghill D.R., Simonoff E., Chan P.K.L., LAU C.Y., Schuemie M.J., Sturkenboom M.C.J.M. and Wong I.C.K., Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study, BMJ. 2017, j2350.


Researcher : LEE KY

List of Research Outputs

Cheung C.L., Ho D.K., SING C.W., TSOI M.F., CHENG K.F., LEE K.Y., Ho Y.N. and Cheung B.M.Y., Randomized controlled trial of the effect of phytosterols-enriched low-fat milk on lipid profile in Chinese, Scientific Reports. 2017, 7: 41084.
Wong H.Y., LEE K.Y. and Cheung C.L., Metabolomics of Sarcopenia in Hong Kong Chinese, The 18th Regional Osteoporosis Conference. Hong Kong. 2017.
Wong H.Y., CHENG K.F., LEE K.Y. and Cheung C.L., Plenary Oral Presentation Award, Korean Endocrine Society. 2017.
Wong H.Y., CHENG K.F., LEE K.Y. and Cheung C.L., Precision Medicine of Denosumab Monotherapy in Osteoporotic Patients, The 5th Seoul International Congress of Endocrinology and Metabolism, SICEM 2017.


Researcher : LEUNG YH

List of Research Outputs

LEUNG Y.H., Cheung B.M.Y., Nguyen U.S., Kung A.W.C., Tan K.C.B. and Cheung C.L., Optimal vitamin D status and its relationship with bone and mineral metabolism in Hong Kong Chinese, Bone. 2017, 97: 293-298.


Researcher : LI D

List of Research Outputs

LI D., CAO H., CHEN J. and Wang Y., Adiponectin-based Therapeutics in Cancer Treatment, Frontiers in Clinical Drug Research - Anti-Cancer Agents. Bentham Science, 2017, 4: 1-52.


Researcher : LI Z

List of Research Outputs

DETREMMERIE C.M.S., CHEN Z., LI Z., ALKHARFY K.M., Leung S.W.S., Xu A., GAO Y. and Vanhoutte P.M.G.R., Endothelium-Dependent Contractions of Isolated Arteries to Thymoquinone Require Biased Activity of Soluble Guanylyl Cyclase with Subsequent Cyclic IMP Production, Journal of Pharmacology and Experimental Therapeutics. 2016, 358: 558-568.


Researcher : Lam JKW

Project Title:Intranasal Delivery of DNA Vaccine using Oligochitosan/PLGA Nanoparticles
Investigator(s):Lam JKW
Department:Pharmacology & Pharmacy
Source(s) of Funding:Health and Medical Research Fund - Full Grant
Start Date:04/2014
Completion Date:08/2016


Project Title:Development of a highly effective, pH responsive peptide, siRNA delivery system to the respiratory tract to combat influenza virus infections
Investigator(s):Lam JKW, Poon LML
Department:Pharmacology & Pharmacy
Source(s) of Funding:General Research Fund (GRF)
Start Date:01/2015


Project Title:Formulation of carrier-free inhalable siRNA powders for the treatment of respiratory diseases
Investigator(s):Lam JKW
Department:Pharmacology & Pharmacy
Source(s) of Funding:Small Project Funding
Start Date:04/2015
Completion Date:06/2017


Project Title:Development of a highly efficient inhalable mucosal DNA vaccine against HIV as dry powder using pH responsive LAH peptides with nuclear localizing sequence as DNA carrier
Investigator(s):Lam JKW, Chen Z, Kwok PCL, Lan Y, Chu YJ
Department:Pharmacology & Pharmacy
Source(s) of Funding:National Natural Science Foundation of China (NSFC) - General Program
Start Date:01/2016


Project Title:Porous nanoparticle aerosol carriers with controllable density for pulmonary drug delivery
Investigator(s):Lam JKW, Kwok PCL
Department:Pharmacology & Pharmacy
Source(s) of Funding:General Research Fund (GRF)
Start Date:01/2016


Project Title:Inhalable dry powder formulation of naked siRNA using spray-drying and spray freeze-drying technologies for the treatment of respiratory infections
Investigator(s):Lam JKW, Kwok PCL
Department:Pharmacology & Pharmacy
Source(s) of Funding:Health and Medical Research Fund - Full Grant
Start Date:04/2016


Project Title:Role of pulmonary surfactants on siRNA delivery to the airway
Investigator(s):Lam JKW
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:04/2016


Project Title:DDL27 Drug Delivery to the Lungs 27; Synthetic KL4 peptide as new carrier of siRNA therapeutics for pulmonary delivery
Investigator(s):Lam JKW
Department:Pharmacology & Pharmacy
Source(s) of Funding:URC/CRCG - Conference Support for Teaching Staff
Start Date:12/2016
Completion Date:12/2016


Project Title:Aerosolized formulation of antifungal drugs for pulmonary fungal infections
Investigator(s):Lam JKW
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:06/2017


List of Research Outputs

CHOW Y.T., Lin H.H.S. and Lam J.K.W., Optimisation of inhalable spray dried powder formulation of small nucleic acids with mannitol and leucine, Drug Delivery to the Lungs 27. 2016.
Casettari L., Fiagioli L., Lucarini S., Lam J.K.W., Cavanagh R. and Stolnik S., Sustainable sugar-based surfactants for innovative drug delivery systems, 6th Pharmaceutical Sciences World Congress, 21-24 May 2017, Stockholm, Sweden . 2017.
Lam J.K.W., Nucleic acid therapy for inhalation, Pharma+Bio Asia 2016 Conference, Kuala Lumpur, Malaysia, 28 September 2016 . 2016.
MAN K.W.D., Lam J.K.W. and Mason A.J., Combination of antimicrobial peptides and isoniazid/rifampicin against multidrug-resistant tuberculosis, 38th Annual Congress of the European Society of Mycobacteriology 2017, 25-28 June 2017, Sibenik, Croatia. 2017.
QIU Y., Lam J.K.W., Leung S.W.S. and Liang W., Delivery of RNAi Therapeutics to the Airways—From Bench to Bedside, Molecules. 2016, 21: 1249.
QIU Y., CHOW Y.T. and Lam J.K.W., Synthetic KL4 peptide as new carrier of siRNA therapeutics for pulmonary delivery, Drug Delivery to the Lungs 27. 2016.
Sze C.W.S., WANG S., NG T.B., Lee C.K.F. and Lam J.K.W., Steroidogenic effect of Erxian decoction for relieving menopause via the p-Akt/PKB pathway in vitro and in vivo, 11th European Congress on Menopause and Andropause.. The Netherland (EMAS 2017), 2017.
WANG S., CHEUNG H.P., Tong Y., LU J., Ng T.B., Zhang Y., Zhang Z., Lee C.K.F., Lam J.K.W. and Sze C.W.S., Steroidogenic effect of Erxian decoction for relieving menopause via the p-Akt/PKB pathway in vitro and in vivo, Journal of Ethnopharmacology. 2017, 195: 188-195.
XU Y., Liang W., Qiu Y., Cespi M., Palmieri G.F., Mason A.J. and Lam J.K.W., Incorporation of a nuclear localization signal in pH responsive LAH4-L1 peptide enhances transfection and nuclear uptake of plasmid DNA, Molecular Pharmaceutics. 2016, 13: 3141-3152.


Researcher : Lam MPS

List of Research Outputs

TSOI M.F., Cheung T.T., Lam M.P.S. and Cheung C.L., Safety of colchicine for gout: a ten-year survey of the Hong Kong population., Presented at the 13th Congress of the European Association for Clinical Pharmacology and Therapeutics, Prague, 2017.. 2017.


Researcher : Leung GPH

Project Title:Cloning and characterization of novel equilibrative nucleoside transporter type 4 (ENT4)
Investigator(s):Leung GPH
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:03/2005


Project Title:Vascular protective effect of narirutin
Investigator(s):Leung GPH
Department:Pharmacology & Pharmacy
Source(s) of Funding:Small Project Funding
Start Date:06/2014


Project Title:Effects of novel Rho kinase inhibitors on human nucleoside transporters
Investigator(s):Leung GPH
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:03/2015
Completion Date:02/2017


Project Title:Protective effects of Pleurotus ostreatus (Oyster mushroom) and ergothioneine against doxorubicin-induced cardiotoxicity
Investigator(s):Leung GPH, Xia Z, Zhang Y, So TH
Department:Pharmacology & Pharmacy
Source(s) of Funding:Health and Medical Research Fund - Full Grant
Start Date:04/2016


Project Title:Role of equilibrative nucleoside transporter-2 in the development of neonatal heart cells
Investigator(s):Leung GPH
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:05/2016


Project Title:Development of novel equilibrative nucleoside transporter-2 inhibitor and its application in studying the functions of equilibrative nucleoside transporter-2 in skeletal muscle
Investigator(s):Leung GPH, Ballard HJ
Department:Pharmacology & Pharmacy
Source(s) of Funding:General Research Fund (GRF)
Start Date:10/2016


Project Title:Role of equilibrative nucleoside transporter-4 in ischemic brain damage
Investigator(s):Leung GPH
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:06/2017


List of Research Outputs

Huang B., Peng Y., Li J., Li S., Sun Y., Wang D., Yang B., Chan J.Y.W., Yu H., Leung G.P.H., Hoi M.P.M., Zhou G.C. and Lee S.M.Y., An andrographolide derivative AGP-26b exhibiting anti-angiogenic activity in HUVECs and zebrafish via blocking the VEGFA/VEGFR2 signaling pathway, Mol. BioSyst.. 2017.
Li Z., Li S., Hu L., Li F., CHEUNG C., SHao W., Que Y., Leung G.P.H. and Yang C., MECHANISMS UNDERLYING ACTION OF XINMAILONG INJECTION, A TRADITIONAL CHINESE MEDICINE, IN CARDIAC FUNCTION IMPROVEMENT, African Journal of Traditional, Complementary and Alternative medicines. 2017, 14: 241-252.
TANG C.T.P., Yang C., Li W.S.R., Lee S.M., Hoi P.M., Chan S.W., Kwan Y.W., Tse C.M. and Leung G.P.H., Inhibition of human equilibrative nucleoside transporters by 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine, European Journal of Pharmacology. 2016, 791: 544-551.
Tsang H.H.L., Vong C.T., Leung G.P.H., Seto S.W., Kwan Y.W., Lee S.M.Y. and Hoi M.P.M., Calycosin and Formononetin Induce Endothelium-Dependent Vasodilation by the Activation of Large-Conductance Ca2+-Activated K+ Channels (BKCa) , Evidence-Based Complementary and Alternative Medicine. 2016, 2016: 1-13.
Yang C., Li Z., Yang S., He Y., Dai R., Leung G.P.H., Pan S., Yang J., Yan R. and Du G., Role of the nicotinic acetylcholine receptor α3 subtype in vascular inflammation, British Journal of Pharmacology. 2016.
Zhou X., Choi P.S., Yang J.M., Or P.M.Y., Hoi P.M., Lee S.M., Leung G.P.H., Ngai S.M., Kong S.K., Ho H.P., Wong M.Y.M., Chan S.W., Yeung J.H.K. and Kwan Y.W., Chemical and pharmacological evaluations on the extract of Scutellaria baicalensis Georgi (Huang-Qin) prepared by various extraction methods, SpringerPlus. 2016, 5.
Zhou X., Cui G., Tseng H.H.L., Lee S.M.Y., Leung G.P.H., Chan S.W., Kwan Y.W. and Hoi M.P.M., Vascular Contributions to Cognitive Impairment and Treatments with Traditional Chinese Medicine, Evidence-Based Complementary and Alternative Medicine. 2016, 2016: 1-12.


Researcher : Leung SWS

Project Title:Therapeutic potential of herbal flavonoids in the management of chronic obstructive pulmonary disease
Investigator(s):Leung SWS, Mak JCW, Man RYK
Department:Pharmacology & Pharmacy
Source(s) of Funding:Health and Medical Research Fund - Full Grant
Start Date:11/2013
Completion Date:07/2017


Project Title:Vasoconstrictor signals in hypoxia: role of soluble guanylyl cyclase
Investigator(s):Leung SWS, Vanhoutte PMGR
Department:Pharmacology & Pharmacy
Source(s) of Funding:General Research Fund (GRF)
Start Date:01/2015


Project Title:Effect s of different components of the Chinese medicine, Astragali Radix (Huangqi), on angiogenic and inflammatory responses of endothelial cells to atherogenic lipoproteins
Investigator(s):Leung SWS
Department:Pharmacology & Pharmacy
Source(s) of Funding:Small Project Funding
Start Date:06/2015
Completion Date:05/2017


Project Title:Vascular effect of thymoquinone, a natural product used in humans as a folk medicine
Investigator(s):Leung SWS, Vanhoutte PMGR
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:06/2016


Project Title:Mechanisms of Vasodilatation: 12th International Symposium; Modulation by fish oil diet of gender differences in the relaxation to adenosine diphosphate in porcine coronary arteries
Investigator(s):Leung SWS
Department:Pharmacology & Pharmacy
Source(s) of Funding:URC/CRCG - Conference Support for Teaching Staff
Start Date:11/2016
Completion Date:11/2016


Project Title:MicroRNA-17-3p curtails endothelial dysfunction and vascular inflammation
Investigator(s):Leung SWS, Vanhoutte PMGR
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:06/2017


Project Title:Effects of microRNA-17-3p upregulation on vascular inflammation and endothelial dysfunction caused by the human immunodeficiency virus proteins
Investigator(s):Leung SWS, Lam JKW, Vanhoutte PMGR
Department:Pharmacology & Pharmacy
Source(s) of Funding:Health and Medical Research Fund - Full Grant
Start Date:06/2017


List of Research Outputs

CHEN H. and Leung S.W.S., AMPK Activator Inhibits EDH-like Relaxations in Superior Mesenteric Arteries of Rats, 12th International Symposium on Healthy Aging, 11-12 March 2017, Hong Kong. 2017.
DETREMMERIE C.M.S., CHEN Z., LI Z., ALKHARFY K.M., Leung S.W.S., Xu A., GAO Y. and Vanhoutte P.M.G.R., Endothelium-Dependent Contractions of Isolated Arteries to Thymoquinone Require Biased Activity of Soluble Guanylyl Cyclase with Subsequent Cyclic IMP Production, Journal of Pharmacology and Experimental Therapeutics. 2016, 358: 558-568.
DETREMMERIE C.M.S., Leung S.W.S., Xu A., Gao Y.S. and Vanhoutte P.M.G.R., Mechanisms of Vasodilatation 12th International Symposium. November 6-9, 2016, Rochester, Minn., USA: Abstracts, Journal of Vascular Research. 2016, 53: 1-70.
Jin J., Tang Q., Li Z., Zhao Z., Zhang Z., Lu L., Zhu T., Vanhoutte P.M.G.R., Leung S.W.S., Tu R. and Shi Y., Prostaglandin E2 regulates renal function in C57/BL6 mouse with 5/6 nephrectomy, Life Sci. 2017, 174: 68-76.
Leung S.W.S. and Vanhoutte P.M.G.R., Endothelium-dependent hyperpolarization: age, gender and blood pressure, do they matter?, Acta Physiol (Oxf). 2017, 219: 108-123.
QIU Y., Lam J.K.W., Leung S.W.S. and Liang W., Delivery of RNAi Therapeutics to the Airways—From Bench to Bedside, Molecules. 2016, 21: 1249.
ZHANG P., Mak J.C.W., Man R.Y.K. and Leung S.W.S., Effects of genistein on inflammatory responses in cigarette smoke-exposed rats, Pharmacology 2016, The Queen Elizabeth II Conference Centre, London, 13-15 December, 2016.


Researcher : Li WSR

List of Research Outputs

TANG C.T.P., Yang C., Li W.S.R., Lee S.M., Hoi P.M., Chan S.W., Kwan Y.W., Tse C.M. and Leung G.P.H., Inhibition of human equilibrative nucleoside transporters by 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine, European Journal of Pharmacology. 2016, 791: 544-551.


Researcher : Li X

Project Title:ISPOR 22nd International Annual Meeting; BUDGET IMPACT AND COST-EFFECTIVENESS ANALYSES OF NEWLY AVAILABLE TREATMENTS FOR CHRONIC HEPATITIS C INFECTION IN HONG KONG
Investigator(s):Li X
Department:Pharmacology & Pharmacy
Source(s) of Funding:URC/CRCG - Conference Support for Teaching Staff
Start Date:05/2017
Completion Date:05/2017


List of Research Outputs

He Y.H., Wong I.C.K., Li X., Anand S., Leung W.K., Siu D.C.W. and Chan E.W., The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies, British Journal of Clinical Pharmacology. 2016, 82(1): 285-300.
LAU C.Y., Li X., Wong I.C.K. and Chan E.W., Bleeding-related hospital admissions and 30-day readmission with dabigatran versus warfarin in patients with non-valvular atrial fibrillation, ISPOR, Boston USA, 20-24th May (Poster) 2017.
LAU C.Y., Li X., Wong I.C.K. and Chan E.W., Hospitalization and Length of Stay among Patients with Non-Valvular Atrial Fibrillation Taking Dabigatran or Warfarin: A Population-Based Cohort Study., ICPE, Dublin, Ireland, 25-28th August . 2016.
Li X., Chan N.S., Tam A.W., Hung F.N.I. and Chan E.W., Budget impact and cost-effectiveness analyses of direct-acting antivirals for chronic hepatitis C virus infection in Hong Kong, European Journal of Clinical Microbiology & Infectious Diseases. 2017.
Li X., Chan S.N., Tam A.W. and Chan E.W., Budget impact and cost-effectiveness analyses of newly available treatments for chronic hepatitis C infection in Hong Kong,, ISPOR 22nd Annual International Meeting 2017.
Li X., Au-Doung L.W. and Chan E.W., The Impact Of Ischemic Stroke On Atrial Fibrillation-related Healthcare Cost: A Systematic Review, ISPOR 7th Asia-Pacific Conference, 3-6th September (Poster). 2016.
Man K.C.K., Li X., Chan E.W. and Wong I.C.K., The Long term use of biologics in Hong Kong., ICPE, Dublin, Ireland, 25-28th August. 2016.


Researcher : Liang W

List of Research Outputs

QIU Y., Lam J.K.W., Leung S.W.S. and Liang W., Delivery of RNAi Therapeutics to the Airways—From Bench to Bedside, Molecules. 2016, 21: 1249.
XU Y., Liang W., Qiu Y., Cespi M., Palmieri G.F., Mason A.J. and Lam J.K.W., Incorporation of a nuclear localization signal in pH responsive LAH4-L1 peptide enhances transfection and nuclear uptake of plasmid DNA, Molecular Pharmaceutics. 2016, 13: 3141-3152.


Researcher : Lui WYV

Project Title:A Precision Therapeutic Tool for Head and Neck Cancer (HNC)
Investigator(s):Lui WYV
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Translational and Applied Research
Start Date:03/2015


Project Title:HKU Overseas Fellowship Awards 2015-16
Investigator(s):Lui WYV
Department:Pharmacology & Pharmacy
Source(s) of Funding:HKU Overseas Fellowship Awards
Start Date:06/2015




Researcher : Luo C

List of Research Outputs

Song E., Jahng J.W., Chong L.P., Sung H.K., Han M., Luo C., Boo S., Hinz B., Cooper M.A., Wang Y., Wu D., Robertson A.A., Berger T., Mak T.W., George I., Schulze P.C. and Sweeney G., Lipocalin-2 induces NLRP3 inflammasome activation via HMGB1 induced TLR4 signaling in heart tissue of mice under pressure overload challenge, Am J Transl Res.. 2017, 9(6): 2723-2735.
Sun W.Y., Yang K., Luo C., Feletou M., Villeneuve N., Vanhoutte P.M.G.R., Xu C. and Wang Y., Role of lipocalin-2 in dietary and aldosterone-induced renal damages, Experimental Biology 2017. The FASEB, 31: Suppl 998.10.
Sun W.Y., Yang K., Luo C., Feletou M., Villeneuve N., Vanhoutte P.M.G.R., Xu A. and Wang Y., Role of lipocalin-2 in dietary and aldosterone-induced renal damages, Experimental Biology 2017. The FASEB, 31.
YANG K., Deng H., MAN W.C., SONG E., Zhang J., Luo C., Cheung B.M.Y., Yuen K.Y., Jensen P.S., Irmukhamedov A., Elie A...G...I...M., Vanhoutte P.M.G.R., Xu A., De Mey J.G.R. and Wang Y., Measuring non-polyaminated lipocalin-2 for cardiometabolic risk assessment, ESC Heart Failure. 2017, 1-13.


Researcher : MAN KWD

List of Research Outputs

MAN K.W.D., Lam J.K.W. and Mason A.J., Combination of antimicrobial peptides and isoniazid/rifampicin against multidrug-resistant tuberculosis, 38th Annual Congress of the European Society of Mycobacteriology 2017, 25-28 June 2017, Sibenik, Croatia. 2017.


Researcher : MAN WC

List of Research Outputs

MAN W.C. and Wang Y., Age-associated Arterial Remodelling and Cardiovascular Diseases, Abnormalities of Vascular System. 2017.
MAN W.C., Overexpression of SIRT1 Selectively in Vascular Endothelium Maintains the Circadian Rhythm of blood Pressure in PER2-deficient Mice, 21st Research Postgraduate Symposium, December 1-2, 2016, Hong Kong. 2016.
Man W.C. and Wang Y., Age-associated arterial remodeling, Abnormalities of Vascular System. 2017, http://openaccessebooks.com/vascular-system.html.
YANG K., Deng H., MAN W.C., SONG E., Zhang J., Luo C., Cheung B.M.Y., Yuen K.Y., Jensen P.S., Irmukhamedov A., Elie A...G...I...M., Vanhoutte P.M.G.R., Xu A., De Mey J.G.R. and Wang Y., Measuring non-polyaminated lipocalin-2 for cardiometabolic risk assessment, ESC Heart Failure. 2017, 1-13.


Researcher : Man KCK

List of Research Outputs

LAO S., Chan E.W., Man K.C.K. and Wong I.C.K., Antipsychotic Prescription Trend in Hong Kong from 2004 to 2014, 32nd ICPE, Dublin, August 25-28, 2016.
Man K.C.K., Li X., Chan E.W. and Wong I.C.K., The Long term use of biologics in Hong Kong., ICPE, Dublin, Ireland, 25-28th August. 2016.


Researcher : Man RYK

List of Research Outputs

ZHANG P., Mak J.C.W., Man R.Y.K. and Leung S.W.S., Effects of genistein on inflammatory responses in cigarette smoke-exposed rats, Pharmacology 2016, The Queen Elizabeth II Conference Centre, London, 13-15 December, 2016.


Researcher : Man WC

List of Research Outputs

MAN W.C. and Wang Y., Age-associated Arterial Remodelling and Cardiovascular Diseases, Abnormalities of Vascular System. 2017.
MAN W.C., Overexpression of SIRT1 Selectively in Vascular Endothelium Maintains the Circadian Rhythm of blood Pressure in PER2-deficient Mice, 21st Research Postgraduate Symposium, December 1-2, 2016, Hong Kong. 2016.
Man W.C. and Wang Y., Age-associated arterial remodeling, Abnormalities of Vascular System. 2017, http://openaccessebooks.com/vascular-system.html.
YANG K., Deng H., MAN W.C., SONG E., Zhang J., Luo C., Cheung B.M.Y., Yuen K.Y., Jensen P.S., Irmukhamedov A., Elie A...G...I...M., Vanhoutte P.M.G.R., Xu A., De Mey J.G.R. and Wang Y., Measuring non-polyaminated lipocalin-2 for cardiometabolic risk assessment, ESC Heart Failure. 2017, 1-13.


Researcher : QIU Y

List of Research Outputs

QIU Y., Lam J.K.W., Leung S.W.S. and Liang W., Delivery of RNAi Therapeutics to the Airways—From Bench to Bedside, Molecules. 2016, 21: 1249.
QIU Y., CHOW Y.T. and Lam J.K.W., Synthetic KL4 peptide as new carrier of siRNA therapeutics for pulmonary delivery, Drug Delivery to the Lungs 27. 2016.
XU Y., Liang W., Qiu Y., Cespi M., Palmieri G.F., Mason A.J. and Lam J.K.W., Incorporation of a nuclear localization signal in pH responsive LAH4-L1 peptide enhances transfection and nuclear uptake of plasmid DNA, Molecular Pharmaceutics. 2016, 13: 3141-3152.


Researcher : Qiu Y

List of Research Outputs

QIU Y., Lam J.K.W., Leung S.W.S. and Liang W., Delivery of RNAi Therapeutics to the Airways—From Bench to Bedside, Molecules. 2016, 21: 1249.
QIU Y., CHOW Y.T. and Lam J.K.W., Synthetic KL4 peptide as new carrier of siRNA therapeutics for pulmonary delivery, Drug Delivery to the Lungs 27. 2016.
XU Y., Liang W., Qiu Y., Cespi M., Palmieri G.F., Mason A.J. and Lam J.K.W., Incorporation of a nuclear localization signal in pH responsive LAH4-L1 peptide enhances transfection and nuclear uptake of plasmid DNA, Molecular Pharmaceutics. 2016, 13: 3141-3152.


Researcher : SING CW

List of Research Outputs

Botzenhardt S., Wong I.C.K., Chan E.W., SING C.W. and Neubert A., Safety profiles of iron chelators in young patients with haemoglobinopathies, Eur J Haematol . 2017, 98(3): 198-217.
Cheung C.L., Ho D.K., SING C.W., TSOI M.F., CHENG K.F., LEE K.Y., Ho Y.N. and Cheung B.M.Y., Randomized controlled trial of the effect of phytosterols-enriched low-fat milk on lipid profile in Chinese, Scientific Reports. 2017, 7: 41084.
LAU C.Y., Chan E.W., Cheung C.L., SING C.W., Man K.C.K., Lip G.Y.H., Siu D.C.W., Lam K.Y.J., Lee C.H.A. and Wong I.C.K., Association Between Dabigatran vs Warfarin and Risk of Osteoporotic Fractures Among Patients With Nonvalvular Atrial Fibrillation, JAMA. 2017, 317: 1151.
Leung Y.H., Han Y., SING C.W., Cheung B.M.Y., Wong I.C.K., Tan K.C.B., Kung A.W.C. and Cheung C.L., Serum 25-hydroxyvitamin D and the risk of stroke in Hong Kong Chinese., Presented at the 20th Anniversary Scientific Meeting of the Institute of Cardiovascular Science and Medicine, 2016.. 2016.
Leung Y.H., Han Y., SING C.W., Cheung B.M.Y., Wong I.C.K., Tan K.C.B., Kung A.W.C. and Cheung C.L., Serum 25-hydroxyvitamin D and the risk of stroke in Hong Kong Chinese, Thrombosis and Haemostasis. 2016, 117: 158-163.
SING C.W. and Cheung C.L., Early Anti-Osteoporosis Treatment and Risk of Mortality After Hip Fracture: A Population Based Study, WCO-IOF-ESCEO Florence 2107, March 23-26, 2017, Florence Italy. 2017.
SING C.W., Wong I.C.K., Cheung B.M.Y., Chan C.Y.J., Chu K.P.J. and Cheung C.L., Incidence and risk estimate of drug-induced agranulocytosis in Hong Kong Chinese. A population-based case-control study, Pharmacoepidemiology and Drug Safety. 2017, 26: 248-255.


Researcher : SONG E

List of Research Outputs

YANG K., Deng H., MAN W.C., SONG E., Zhang J., Luo C., Cheung B.M.Y., Yuen K.Y., Jensen P.S., Irmukhamedov A., Elie A...G...I...M., Vanhoutte P.M.G.R., Xu A., De Mey J.G.R. and Wang Y., Measuring non-polyaminated lipocalin-2 for cardiometabolic risk assessment, ESC Heart Failure. 2017, 1-13.


Researcher : Sun WY

Project Title:Experimental Biology Meeting 2017; Role of lipocalin-2 in dietary or aldosterone-induced renal damages
Investigator(s):Sun WY
Department:Pharmacology & Pharmacy
Source(s) of Funding:URC/CRCG - Conference Support for Teaching Staff
Start Date:04/2017
Completion Date:04/2017


List of Research Outputs

Sun W.Y. and Wang Y., Calorie restriction mimetics from functional foods: impact on promoting healthy lifespan, Nutrition and Functional Foods for Healthy Aging, publisher. Elesvier, 2017.
Sun W.Y., Yang K., Luo C., Feletou M., Villeneuve N., Vanhoutte P.M.G.R., Xu C. and Wang Y., Role of lipocalin-2 in dietary and aldosterone-induced renal damages, Experimental Biology 2017. The FASEB, 31: Suppl 998.10.
Sun W.Y., Yang K., Luo C., Feletou M., Villeneuve N., Vanhoutte P.M.G.R., Xu A. and Wang Y., Role of lipocalin-2 in dietary and aldosterone-induced renal damages, Experimental Biology 2017. The FASEB, 31.


Researcher : TANG CTP

List of Research Outputs

TANG C.T.P., Yang C., Li W.S.R., Lee S.M., Hoi P.M., Chan S.W., Kwan Y.W., Tse C.M. and Leung G.P.H., Inhibition of human equilibrative nucleoside transporters by 4-((4-(2-fluorophenyl)piperazin-1-yl)methyl)-6-imino-N-(naphthalen-2-yl)-1,3,5-triazin-2-amine, European Journal of Pharmacology. 2016, 791: 544-551.


Researcher : Tam AW

List of Research Outputs

LAO S., Tam A.W., Wong I.C.K., Besag F.M.C., Man K.C.K., Chui S.L.C. and Chan E.W., Prescribing trends and indications of antipsychotic medication in Hong Kong from 2004 to 2014: General and vulnerable patient groups, Pharmacoepidemiology and Drug Safety. 2017.
Li X., Chan N.S., Tam A.W., Hung F.N.I. and Chan E.W., Budget impact and cost-effectiveness analyses of direct-acting antivirals for chronic hepatitis C virus infection in Hong Kong, European Journal of Clinical Microbiology & Infectious Diseases. 2017.
Li X., Chan S.N., Tam A.W. and Chan E.W., Budget impact and cost-effectiveness analyses of newly available treatments for chronic hepatitis C infection in Hong Kong,, ISPOR 22nd Annual International Meeting 2017.


Researcher : Tang EHC

Project Title:Telomere-independent Rap1 contributes to inflammation during atherosclerosis
Investigator(s):Tang EHC, Man RYK, Leung SWS
Department:Pharmacology & Pharmacy
Source(s) of Funding:National Natural Science Foundation of China (NSFC) - General Program
Start Date:01/2013


Project Title:Regulation of triglyceride metabolism by prostaglandin E receptor subtype 4
Investigator(s):Tang EHC
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:05/2013


Project Title:Rap1 aggravates the development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice.
Investigator(s):Tang EHC
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:06/2014


Project Title:Enhancement of the fat-burning capacity of white and brown adipose tissue by activation of prostaglandin E receptor subtype 4
Investigator(s):Tang EHC
Department:Pharmacology & Pharmacy
Source(s) of Funding:Early Career Scheme (ECS)
Start Date:12/2014


Project Title:Unexpected role of the telomere-associated protein Rap1 in protecting against endothelial dysfunction
Investigator(s):Tang EHC, Vanhoutte PMGR, Xu A
Department:Pharmacology & Pharmacy
Source(s) of Funding:General Research Fund (GRF)
Start Date:01/2017


List of Research Outputs

Cai Y., PANG L., Tang E.H.C., Irwin M.G. and Xia Z., COX-2 inhibition protects against hypoxia/reoxygenation-induced cardiomyocyte apoptosis viaAkt-dependent enhancentment of iNOS expression, 14th Annual Meeting of the Society for Heart and Vascular Metabolism. 2016.
PANG L., Cai Y., Tang E.H.C., YAN D., Li H., IRWIN M.G., MA H., Xia Z. and RAMOJI K., COX-2 inhibition protects against hypoxia/reoxygenation-induced cardiomyocyte apoptosis via Akt-dependent enhancentment of iNOS expression, Oxidative Medicine and Cellular Longevity. 2016.
YING F. and Tang E.H.C., Deficiency of Prostaglandin E Receptor Subtype 4 (EP4) Favored Multilocular Fat Cell Formation and Increased Mitochondrial Biogenesis through the AMPK-FSP27 Axis, 12th International Symposium on Healthy Aging, 11-12 March 2017, Hong Kong. 2017.
YING F., Cai Y., Wong H.K., Lee T. and Tang E.H.C., Disturbed cholesterol homeostasis in prostaglandin E receptor 4 knockout mice model, The 6th ICCR Congress on Chronic societal Cardiometabolic Diseases. 2017.
YING F., Cai Y. and Tang E.H.C., Prostaglandin E receptor subtype 4 (EP4) regulates lipid droplet size and mitochondrial activity via FSP27 in white adipose tissue, Metabolic Diseases; Breakthrough Discoveries in Diabetes & Obesity, Novotel Melbourne St Kilda, 1-2 December 2016.
YING F., Cai Y., CAI Y., Wang Y. and Tang E.H.C., Prostaglandin E receptor subtype 4 regulates lipid droplet size and mitochondrial activity in murine subcutaneous white adipose tissue, The FASEB Journal. 2017, 331: 4023-4036.
YING F., Cai Y. and Tang E.H.C., Prostaglandin receptor subtype 4 (EP4) deficiency enhanced multilocular fat cell formation and mitochondrial biogenesis and facilated wat remodeling, The 6th ICCR Congress on Chronic Societal Cardiometabolic Diseases, May 15-17, 2017, Quebec Canada. 2017.


Researcher : Tang HC

Project Title:Telomere-independent Rap1 contributes to inflammation during atherosclerosis
Investigator(s):Tang EHC, Man RYK, Leung SWS
Department:Pharmacology & Pharmacy
Source(s) of Funding:National Natural Science Foundation of China (NSFC) - General Program
Start Date:01/2013


Project Title:Regulation of triglyceride metabolism by prostaglandin E receptor subtype 4
Investigator(s):Tang EHC
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:05/2013


Project Title:Rap1 aggravates the development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice.
Investigator(s):Tang EHC
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:06/2014


Project Title:Enhancement of the fat-burning capacity of white and brown adipose tissue by activation of prostaglandin E receptor subtype 4
Investigator(s):Tang EHC
Department:Pharmacology & Pharmacy
Source(s) of Funding:Early Career Scheme (ECS)
Start Date:12/2014


Project Title:Unexpected role of the telomere-associated protein Rap1 in protecting against endothelial dysfunction
Investigator(s):Tang EHC, Vanhoutte PMGR, Xu A
Department:Pharmacology & Pharmacy
Source(s) of Funding:General Research Fund (GRF)
Start Date:01/2017


List of Research Outputs



Researcher : Tom WM

Project Title:VII World Conference on Clinical Pharmacology and Therapeutics 4th Congress of the European Association for Clinical Pharmacology and Therapeutics Antidotal Mechanisms of Hydroxyacetone and Dihydroxyacetone in the Treatment of Acute Acetonitrile Poisoning
Investigator(s):Tom WM
Department:Pharmacology & Pharmacy
Source(s) of Funding:URC/CRCG - Conference Support for Teaching Staff
Start Date:07/2000




Researcher : Tong HYH

List of Research Outputs

Anand S., Tong H.Y.H., Besag F.M.C., Chan E.W., Cortese S. and Wong I.C.K., Safety, Tolerability And Efficacy Of Drugs For Treating Behavioural Insomnia In Children With Attention-deficit/hyperactivity Disorder: A Systematic Review With Methodological Quality Assessment. , Pediatr Drugs . 2017, 19(3): 235-250.


Researcher : Vanhoutte P.M.G.

Project Title:Annual Summer School in Danish Cardiovascular Research Academy Veins in health and disease
Investigator(s):Vanhoutte PMGR
Department:Pharmacology & Pharmacy
Source(s) of Funding:URC/CRCG - Conference Support for Teaching Staff
Start Date:06/2007


Project Title:Visiting Research Professors Scheme 2009-10
Investigator(s):Vanhoutte PMGR
Department:Pharmacology & Pharmacy
Source(s) of Funding:Visiting Research Professors Scheme
Start Date:09/2009


Project Title:A Study of the Relative Significance of Nitric Oxide Synthase vs NADPH oxidase in Endothelial Senescence
Investigator(s):Vanhoutte PMGR, Wang Y
Department:Pharmacology & Pharmacy
Source(s) of Funding:Small Project Funding
Start Date:10/2009


Project Title:Human Prostacyclin Receptors and Endothelial Dysfunction
Investigator(s):Vanhoutte PMGR, Xu A, Wang Y, Leung SWS
Department:Pharmacology & Pharmacy
Source(s) of Funding:Health and Medical Research Fund - Full Grant
Start Date:04/2016


List of Research Outputs



Researcher : Vanhoutte PMGR

Project Title:Annual Summer School in Danish Cardiovascular Research Academy Veins in health and disease
Investigator(s):Vanhoutte PMGR
Department:Pharmacology & Pharmacy
Source(s) of Funding:URC/CRCG - Conference Support for Teaching Staff
Start Date:06/2007


Project Title:Visiting Research Professors Scheme 2009-10
Investigator(s):Vanhoutte PMGR
Department:Pharmacology & Pharmacy
Source(s) of Funding:Visiting Research Professors Scheme
Start Date:09/2009


Project Title:A Study of the Relative Significance of Nitric Oxide Synthase vs NADPH oxidase in Endothelial Senescence
Investigator(s):Vanhoutte PMGR, Wang Y
Department:Pharmacology & Pharmacy
Source(s) of Funding:Small Project Funding
Start Date:10/2009


Project Title:Human Prostacyclin Receptors and Endothelial Dysfunction
Investigator(s):Vanhoutte PMGR, Xu A, Wang Y, Leung SWS
Department:Pharmacology & Pharmacy
Source(s) of Funding:Health and Medical Research Fund - Full Grant
Start Date:04/2016


List of Research Outputs

Baretella O.M., Chung S.K., Xu A. and Vanhoutte P.M.G.R., Endothelial overexpression of endothelin-1 modulates aortic, carotid, iliac and renal arterial responses in obese mice, Acta Pharmacologica Sinica. 2017, 38: 498-512.
DETREMMERIE C.M.S., CHEN Z., LI Z., ALKHARFY K.M., Leung S.W.S., Xu A., GAO Y. and Vanhoutte P.M.G.R., Endothelium-Dependent Contractions of Isolated Arteries to Thymoquinone Require Biased Activity of Soluble Guanylyl Cyclase with Subsequent Cyclic IMP Production, Journal of Pharmacology and Experimental Therapeutics. 2016, 358: 558-568.
DETREMMERIE C.M.S., Leung S.W.S., Xu A., Gao Y.S. and Vanhoutte P.M.G.R., Mechanisms of Vasodilatation 12th International Symposium. November 6-9, 2016, Rochester, Minn., USA: Abstracts, Journal of Vascular Research. 2016, 53: 1-70.
Feletou M. and Vanhoutte P.M.G.R., Endothelium-dependent hyperpolarizations: Quo vadis?, Acta Physiologica. 2017, 219: 100-107.
Jin J., Tang Q., Li Z., Zhao Z., Zhang Z., Lu L., Zhu T., Vanhoutte P.M.G.R., Leung S.W.S., Tu R. and Shi Y., Prostaglandin E2 regulates renal function in C57/BL6 mouse with 5/6 nephrectomy, Life Sci. 2017, 174: 68-76.
Leung S.W.S. and Vanhoutte P.M.G.R., Endothelium-dependent hyperpolarization: age, gender and blood pressure, do they matter?, Acta Physiol (Oxf). 2017, 219: 108-123.
Miller V.M., Webb R.C. and Vanhoutte P.M.G.R., 12th International Symposium for Mechanisms of Vasodilatation: Celebrating the 30th Anniversary of the Announcement of NO as a Vasodilator Molecule, J Cardiovasc Pharmacol. 2017, 69(5): 245-247.
Sun W.Y., Yang K., Luo C., Feletou M., Villeneuve N., Vanhoutte P.M.G.R., Xu C. and Wang Y., Role of lipocalin-2 in dietary and aldosterone-induced renal damages, Experimental Biology 2017. The FASEB, 31: Suppl 998.10.
Sun W.Y., Yang K., Luo C., Feletou M., Villeneuve N., Vanhoutte P.M.G.R., Xu A. and Wang Y., Role of lipocalin-2 in dietary and aldosterone-induced renal damages, Experimental Biology 2017. The FASEB, 31.
Vanhoutte P.M.G.R., An old wheel gets a new CART …, European Heart Journal. 2016, 38: ehw508.
YANG K., Deng H., MAN W.C., SONG E., Zhang J., Luo C., Cheung B.M.Y., Yuen K.Y., Jensen P.S., Irmukhamedov A., Elie A...G...I...M., Vanhoutte P.M.G.R., Xu A., De Mey J.G.R. and Wang Y., Measuring non-polyaminated lipocalin-2 for cardiometabolic risk assessment, ESC Heart Failure. 2017, 1-13.
Zhou M., Bao Y., LI H., PAN Y., SHU L., Xia Z., Wu D., Vanhoutte P.M.G.R., Xu A., Jia W. and Hoo R.L.C., Deficiency of adipocyte fatty-acid-binding protein alleviates myocardial ischaemia/reperfusion injury and diabetes-induced cardiac dysfunction., Clinical Science. 2016.


Researcher : Verhoeft KR

List of Research Outputs

Li Y.Y., Chung G.T., Lui W.Y.V., To K.F., Ma B.B., Chow C., Woo J.K., Yip K.Y., Seo J., Hui E.P., Mak M.K., Rusan M., Chau N.G., Or Y.Y., Law M.H., Law P.P., Liu Z.W., NGAN H.L., Hau P.M., Verhoeft K.R., Poon P.H., Yoo S.K., Shin J.Y., Lee S.D., Lun S.W., Jia L.J., Chan A.W., Chan J.Y., Lai P.B., Fung C.Y., Hung S.T., Wang L., Chang A.M., Chiosea S.I., Hedberg M.L., Tsao G.S.W., van Hasselt A.C., Chan A.T., Grandis J.R., Nature Communications P.S. and Lo K.W., Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations, Nature Communications. 2017.


Researcher : WANG Y

List of Research Outputs

Gong Q., Hu Z., Zhang F., Cui A., Chen X., Jiang H., Gao J., Chen X., Han Y., Liang Q., Ye D., Shi L., Chin Y.E., Wang Y., Xiao H., Guo F., Liu Y., Zang M., Xu A. and Li Y., Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice, Hepatology. 2016, 64: 425-438.
Hui X., Gu P., Zhang J., Wang Y. and Xu A., 2016 Research Output Award, The University of Hong Kong. 2016.
Hui X., Gao Y., Wang Y. and Xu A., Adipocyte SIRT1 controls systemic insulin sensitivity by modulating macrophages in adipose tissue, EMBO reports. 2017, 18: 645-657.
LI D., CAO H., CHEN J. and Wang Y., Adiponectin-based Therapeutics in Cancer Treatment, Frontiers in Clinical Drug Research - Anti-Cancer Agents. Bentham Science, 2017, 4: 1-52.
LUO D., Huang M., Guo Y., Li D., CHENG Y., Zhao J., Wang Y. and Rong J., Plant-derived triterpenoid celastrol ameliorates inflammation and metabolic dysfunctions in adipose tissues via covalent modification of ER chaperone GRP78/BiP, Keystone Symposia: Neuronal Control of Appetite, Metabolism and Weight. 9–13 May 2017, København V, Denmark. 2017.
MAN W.C. and Wang Y., Age-associated Arterial Remodelling and Cardiovascular Diseases, Abnormalities of Vascular System. 2017.
Man W.C. and Wang Y., Age-associated arterial remodeling, Abnormalities of Vascular System. 2017, http://openaccessebooks.com/vascular-system.html.
Mao L., Nie B., Nie T., Hui X., Gao X., Lin X., Liu X., Xu Y., Tang X., Yuan R., Li K., Li P., Ding K., Wang Y., Xu A., Fei J., Han W., Liu P., Madsen L., Kristansen K., Zhou Z., Deng S. and Wu D., Visualization and Quantification of Browning Using a Ucp1 -2A-Luciferase Knock-in Mouse Model , Diabetes. 2017, 66: 407-417.
Song E., Jahng J.W., Chong L.P., Sung H.K., Han M., Luo C., Boo S., Hinz B., Cooper M.A., Wang Y., Wu D., Robertson A.A., Berger T., Mak T.W., George I., Schulze P.C. and Sweeney G., Lipocalin-2 induces NLRP3 inflammasome activation via HMGB1 induced TLR4 signaling in heart tissue of mice under pressure overload challenge, Am J Transl Res.. 2017, 9(6): 2723-2735.
Sun W.Y. and Wang Y., Calorie restriction mimetics from functional foods: impact on promoting healthy lifespan, Nutrition and Functional Foods for Healthy Aging, publisher. Elesvier, 2017.
Sun W.Y., Yang K., Luo C., Feletou M., Villeneuve N., Vanhoutte P.M.G.R., Xu C. and Wang Y., Role of lipocalin-2 in dietary and aldosterone-induced renal damages, Experimental Biology 2017. The FASEB, 31: Suppl 998.10.
Sun W.Y., Yang K., Luo C., Feletou M., Villeneuve N., Vanhoutte P.M.G.R., Xu A. and Wang Y., Role of lipocalin-2 in dietary and aldosterone-induced renal damages, Experimental Biology 2017. The FASEB, 31.
WANG Y., TSE M.A., LIU Y., Zhu C.F., Liang Q. and Xu A., High Intensity Exercise: A Multi-beneficial Exercise Modality to Promote Browning of White Adipose Tissue, Reduce Fat Accumulation and Control Metabolic Disease, 10th International Conference on Strength Training, Kyoto, Japan, November 30-December 2, 2016.
YANG K., Deng H., MAN W.C., SONG E., Zhang J., Luo C., Cheung B.M.Y., Yuen K.Y., Jensen P.S., Irmukhamedov A., Elie A...G...I...M., Vanhoutte P.M.G.R., Xu A., De Mey J.G.R. and Wang Y., Measuring non-polyaminated lipocalin-2 for cardiometabolic risk assessment, ESC Heart Failure. 2017, 1-13.
YING F., Cai Y., CAI Y., Wang Y. and Tang E.H.C., Prostaglandin E receptor subtype 4 regulates lipid droplet size and mitochondrial activity in murine subcutaneous white adipose tissue, The FASEB Journal. 2017, 331: 4023-4036.


Researcher : WONG YS

List of Research Outputs

CHUI S.L.C., WONG Y.S., Lee H.M.E., Chang W.C., Chen E.Y.H., Wong I.C.K. and Chan E.W., Potential association between the use of oral fluoroquinolones and acute neuropsychiatric disorders in Hong Kong: a self-controlled case series study., ICPE, Dublin, Ireland, 25-28th August . 2016.
CHUI S.L.C., Wong I.C.K., WONG Y.S., LEE E.H.M., CHANG W.C., CHEN E.Y.H. and Chan E.W., The Association Between the Use of Oral Fluoroquinolones and Neuropsychiatric Events: A Self-Controlled Case Series Study, 32nd ICPE, Dublin, August 25-28, 2016.
Leung W.K., Chan E.W., Wong Y.S., Chen L., Wong O.L., Wong I.C. and Cheung M.K.S., Age of Helicobacter pylori Eradication and Subsequent Risk of Gastric Cancer Development: A Population-Based Study, Digestive Disease Week, 6-9 May 2017, Chicago, USA. 2017.
WONG Y.S., Chan E.W., Anand S., Worsley A.J. and Wong I.C.K., Managing cardiovascular risk of macrolides: systematic review and meta-analysis. , Drug Saf . 2017.
WONG Y.S., Wong I.C.K., CHUI S.L.C., LEE E.H.M., CHANG W.C., CHEN E.Y.H., LEUNG W.K. and Chan E.W., Neuropsychiatric Events Associated with the Use of Helicobacter Pylori Eradication Therapy Containing-Clarithromycin: Self-Controlled Case Series, 32nd ICPE, Dublin, August 26-28, 2016.


Researcher : Wang Y

Project Title:Outstanding Young Researcher Award 2009-10
Investigator(s):Wang Y
Department:Pharmacology & Pharmacy
Source(s) of Funding:Outstanding Young Researcher Award
Start Date:12/2010


Project Title:HERC2 as a regulator of endothelial senescence by modulating SIRT1/LKB1 signaling axis
Investigator(s):Wang Y, Tse HF
Department:Pharmacology & Pharmacy
Source(s) of Funding:General Research Fund (GRF)
Start Date:01/2014
Completion Date:12/2016


Project Title:Molecular dissection of the pathogenic adipose-vascular signaling axis associated with obesity - focusing on polyamination and deamidation of lipocalin-2
Investigator(s):Wang Y, Yuen KY
Department:Pharmacology & Pharmacy
Source(s) of Funding:General Research Fund (GRF)
Start Date:01/2015


Project Title:Role of Endothelial SIRT1 in the Prevention of Vascular Ageing - focusing on arterial remodeling and circadian rhythmicity
Investigator(s):Wang Y, Vanhoutte PMGR
Department:Pharmacology & Pharmacy
Source(s) of Funding:Health and Medical Research Fund - Full Grant
Start Date:09/2016


Project Title:Timely resetting mitochondrial function by SIRT1 in adipose tissue determines the pace of metabolic ageing in mice
Investigator(s):Wang Y
Department:Pharmacology & Pharmacy
Source(s) of Funding:General Research Fund (GRF)
Start Date:01/2017


Project Title:Role of lipocalin-2 in adipose tissue expansion, phenotypic switching and fibrotic damages during the development of cardiometabolic syndrome
Investigator(s):Wang Y, Sun WY
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:06/2017


List of Research Outputs

Gong Q., Hu Z., Zhang F., Cui A., Chen X., Jiang H., Gao J., Chen X., Han Y., Liang Q., Ye D., Shi L., Chin Y.E., Wang Y., Xiao H., Guo F., Liu Y., Zang M., Xu A. and Li Y., Fibroblast growth factor 21 improves hepatic insulin sensitivity by inhibiting mammalian target of rapamycin complex 1 in mice, Hepatology. 2016, 64: 425-438.
Hui X., Gu P., Zhang J., Wang Y. and Xu A., 2016 Research Output Award, The University of Hong Kong. 2016.
Hui X., Gao Y., Wang Y. and Xu A., Adipocyte SIRT1 controls systemic insulin sensitivity by modulating macrophages in adipose tissue, EMBO reports. 2017, 18: 645-657.
LI D., CAO H., CHEN J. and Wang Y., Adiponectin-based Therapeutics in Cancer Treatment, Frontiers in Clinical Drug Research - Anti-Cancer Agents. Bentham Science, 2017, 4: 1-52.
LUO D., Huang M., Guo Y., Li D., CHENG Y., Zhao J., Wang Y. and Rong J., Plant-derived triterpenoid celastrol ameliorates inflammation and metabolic dysfunctions in adipose tissues via covalent modification of ER chaperone GRP78/BiP, Keystone Symposia: Neuronal Control of Appetite, Metabolism and Weight. 9–13 May 2017, København V, Denmark. 2017.
MAN W.C. and Wang Y., Age-associated Arterial Remodelling and Cardiovascular Diseases, Abnormalities of Vascular System. 2017.
Man W.C. and Wang Y., Age-associated arterial remodeling, Abnormalities of Vascular System. 2017, http://openaccessebooks.com/vascular-system.html.
Mao L., Nie B., Nie T., Hui X., Gao X., Lin X., Liu X., Xu Y., Tang X., Yuan R., Li K., Li P., Ding K., Wang Y., Xu A., Fei J., Han W., Liu P., Madsen L., Kristansen K., Zhou Z., Deng S. and Wu D., Visualization and Quantification of Browning Using a Ucp1 -2A-Luciferase Knock-in Mouse Model , Diabetes. 2017, 66: 407-417.
Song E., Jahng J.W., Chong L.P., Sung H.K., Han M., Luo C., Boo S., Hinz B., Cooper M.A., Wang Y., Wu D., Robertson A.A., Berger T., Mak T.W., George I., Schulze P.C. and Sweeney G., Lipocalin-2 induces NLRP3 inflammasome activation via HMGB1 induced TLR4 signaling in heart tissue of mice under pressure overload challenge, Am J Transl Res.. 2017, 9(6): 2723-2735.
Sun W.Y. and Wang Y., Calorie restriction mimetics from functional foods: impact on promoting healthy lifespan, Nutrition and Functional Foods for Healthy Aging, publisher. Elesvier, 2017.
Sun W.Y., Yang K., Luo C., Feletou M., Villeneuve N., Vanhoutte P.M.G.R., Xu C. and Wang Y., Role of lipocalin-2 in dietary and aldosterone-induced renal damages, Experimental Biology 2017. The FASEB, 31: Suppl 998.10.
Sun W.Y., Yang K., Luo C., Feletou M., Villeneuve N., Vanhoutte P.M.G.R., Xu A. and Wang Y., Role of lipocalin-2 in dietary and aldosterone-induced renal damages, Experimental Biology 2017. The FASEB, 31.
WANG Y., TSE M.A., LIU Y., Zhu C.F., Liang Q. and Xu A., High Intensity Exercise: A Multi-beneficial Exercise Modality to Promote Browning of White Adipose Tissue, Reduce Fat Accumulation and Control Metabolic Disease, 10th International Conference on Strength Training, Kyoto, Japan, November 30-December 2, 2016.
YANG K., Deng H., MAN W.C., SONG E., Zhang J., Luo C., Cheung B.M.Y., Yuen K.Y., Jensen P.S., Irmukhamedov A., Elie A...G...I...M., Vanhoutte P.M.G.R., Xu A., De Mey J.G.R. and Wang Y., Measuring non-polyaminated lipocalin-2 for cardiometabolic risk assessment, ESC Heart Failure. 2017, 1-13.
YING F., Cai Y., CAI Y., Wang Y. and Tang E.H.C., Prostaglandin E receptor subtype 4 regulates lipid droplet size and mitochondrial activity in murine subcutaneous white adipose tissue, The FASEB Journal. 2017, 331: 4023-4036.


Researcher : Wang Y.

Project Title:Outstanding Young Researcher Award 2009-10
Investigator(s):Wang Y
Department:Pharmacology & Pharmacy
Source(s) of Funding:Outstanding Young Researcher Award
Start Date:12/2010


Project Title:HERC2 as a regulator of endothelial senescence by modulating SIRT1/LKB1 signaling axis
Investigator(s):Wang Y, Tse HF
Department:Pharmacology & Pharmacy
Source(s) of Funding:General Research Fund (GRF)
Start Date:01/2014
Completion Date:12/2016


Project Title:Molecular dissection of the pathogenic adipose-vascular signaling axis associated with obesity - focusing on polyamination and deamidation of lipocalin-2
Investigator(s):Wang Y, Yuen KY
Department:Pharmacology & Pharmacy
Source(s) of Funding:General Research Fund (GRF)
Start Date:01/2015


Project Title:Role of Endothelial SIRT1 in the Prevention of Vascular Ageing - focusing on arterial remodeling and circadian rhythmicity
Investigator(s):Wang Y, Vanhoutte PMGR
Department:Pharmacology & Pharmacy
Source(s) of Funding:Health and Medical Research Fund - Full Grant
Start Date:09/2016


Project Title:Timely resetting mitochondrial function by SIRT1 in adipose tissue determines the pace of metabolic ageing in mice
Investigator(s):Wang Y
Department:Pharmacology & Pharmacy
Source(s) of Funding:General Research Fund (GRF)
Start Date:01/2017


Project Title:Role of lipocalin-2 in adipose tissue expansion, phenotypic switching and fibrotic damages during the development of cardiometabolic syndrome
Investigator(s):Wang Y, Sun WY
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:06/2017


List of Research Outputs



Researcher : Wong FFC

List of Research Outputs

Chung A.Y.S., Anand S., Wong I.C.K., Tan K.C.B., Wong F.F.C., Chui C.M.W. and Chan E.W., Improving medication safety and diabetes management in Hong Kong – A multi-disciplinary approach., Hong Kong Med. J. . 2017, 23(2): 158-167.


Researcher : Wong HK

List of Research Outputs

YING F., Cai Y., Wong H.K., Lee T. and Tang E.H.C., Disturbed cholesterol homeostasis in prostaglandin E receptor 4 knockout mice model, The 6th ICCR Congress on Chronic societal Cardiometabolic Diseases. 2017.


Researcher : Wong HY

List of Research Outputs

Wong H.Y., LEE K.Y. and Cheung C.L., Metabolomics of Sarcopenia in Hong Kong Chinese, The 18th Regional Osteoporosis Conference. Hong Kong. 2017.
Wong H.Y., CHENG K.F., LEE K.Y. and Cheung C.L., Plenary Oral Presentation Award, Korean Endocrine Society. 2017.
Wong H.Y., CHENG K.F., LEE K.Y. and Cheung C.L., Precision Medicine of Denosumab Monotherapy in Osteoporotic Patients, The 5th Seoul International Congress of Endocrinology and Metabolism, SICEM 2017.


Researcher : Wong ICK

Project Title:Feasibility study of the effects of clonidine and melatonin treatment on sleep architecture of children with ADHD.
Investigator(s):Wong ICK
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Translational and Applied Research
Start Date:04/2015


List of Research Outputs

Anand S., Tong H.Y.H., Besag F.M.C., Chan E.W., Cortese S. and Wong I.C.K., Safety, Tolerability And Efficacy Of Drugs For Treating Behavioural Insomnia In Children With Attention-deficit/hyperactivity Disorder: A Systematic Review With Methodological Quality Assessment. , Pediatr Drugs . 2017, 19(3): 235-250.
Botzenhardt S., Wong I.C.K., Chan E.W., SING C.W. and Neubert A., Safety profiles of iron chelators in young patients with haemoglobinopathies, Eur J Haematol . 2017, 98(3): 198-217.
CHUI S.L.C., WONG Y.S., Lee H.M.E., Chang W.C., Chen E.Y.H., Wong I.C.K. and Chan E.W., Potential association between the use of oral fluoroquinolones and acute neuropsychiatric disorders in Hong Kong: a self-controlled case series study., ICPE, Dublin, Ireland, 25-28th August . 2016.
CHUI S.L.C., Wong I.C.K., WONG Y.S., LEE E.H.M., CHANG W.C., CHEN E.Y.H. and Chan E.W., The Association Between the Use of Oral Fluoroquinolones and Neuropsychiatric Events: A Self-Controlled Case Series Study, 32nd ICPE, Dublin, August 25-28, 2016.
Chan P.H.M., Hai S.H.J.J., Huang D., Ho M.H., Chan E.W., Cheung B.M.Y., Wong I.C.K., Tse H.F., Hung F.N.I. and Siu D.C.W., Burden of upper gastrointestinal symptoms in patients prescribed Dabigatran for stroke prevention., Sage Open Medicine . 2016, 4:2050312116662414.
Chung A.Y., Anand S., Wong I.C.K., Tan K.C.B., Wong C.F., Chui C.M.W. and Chan E.W., Improving medication safety and diabetes management in Hong Kong: a multidisciplinary approach, Hong Kong Medical Journal. 2017, 23(2): 158-67.
Chung A.Y.S., Anand S., Wong I.C.K., Tan K.C.B., Wong F.F.C., Chui C.M.W. and Chan E.W., Improving medication safety and diabetes management in Hong Kong – A multi-disciplinary approach., Hong Kong Med. J. . 2017, 23(2): 158-167.
He Y.H., Wong I.C.K., Li X., Anand S., Leung W.K., Siu D.C.W. and Chan E.W., The association between non-vitamin K antagonist oral anticoagulants and gastrointestinal bleeding: a meta-analysis of observational studies, British Journal of Clinical Pharmacology. 2016, 82(1): 285-300.
LAO S., Chan E.W., Man K.C.K. and Wong I.C.K., Antipsychotic Prescription Trend in Hong Kong from 2004 to 2014, 32nd ICPE, Dublin, August 25-28, 2016.
LAO S., HE Y., Wong I.C.K., BESAG F.M.C. and Chan E.W., Tolerability/Safety Profile of Cariprazine in Treating Psychotic Disorders/Bipolar Disorder: A Systematic Review with Meta-Analysis of RCTs , 32nd ICPE, Dublin, August 25-28, 2016.
LAU C.Y., Li X., Wong I.C.K. and Chan E.W., Bleeding-related hospital admissions and 30-day readmission with dabigatran versus warfarin in patients with non-valvular atrial fibrillation, ISPOR, Boston USA, 20-24th May (Poster) 2017.
LAU C.Y., Chan E.W. and Wong I.C.K., Dabigatran versus Warfarin in Patients with Non-Valvular Atrial Fibrillation: A Population-Wide Cohort Study in Chinese Patients. , ICPE, Dublin, Ireland, 25-28th August.. 2016.
LAU C.Y., Li X., Wong I.C.K. and Chan E.W., Hospitalization and Length of Stay among Patients with Non-Valvular Atrial Fibrillation Taking Dabigatran or Warfarin: A Population-Based Cohort Study., ICPE, Dublin, Ireland, 25-28th August . 2016.
Leung Y.H., Cheung B.M.Y., Wong I.C.K., Tan K.C.B., Kung A.W.C. and Cheung C.L., 25-hydroxyvitamin D and the risk of incident diabetes in Hong Kong Chinese., Presented at the 13th Congress of the European Association for Clinical Pharmacology and Therapeutics, Prague, 2017.. 2017.
Leung Y.H., Cheung B.M.Y., Wong I.C.K., Tan K.C.B., Kung A.W.C. and Cheung C.L., 25-hydroxyvitamin D and the risk of incident diabetes in Hong Kong Chinese., Presented at the 5th Seoul International Congress of Endocrinology and Metabolism 2017.. 2017.
Leung Y.H., Han Y., SING C.W., Cheung B.M.Y., Wong I.C.K., Tan K.C.B., Kung A.W.C. and Cheung C.L., Serum 25-hydroxyvitamin D and the risk of stroke in Hong Kong Chinese., Presented at the 20th Anniversary Scientific Meeting of the Institute of Cardiovascular Science and Medicine, 2016.. 2016.
Leung Y.H., Han Y., SING C.W., Cheung B.M.Y., Wong I.C.K., Tan K.C.B., Kung A.W.C. and Cheung C.L., Serum 25-hydroxyvitamin D and the risk of stroke in Hong Kong Chinese, Thrombosis and Haemostasis. 2016, 117: 158-163.
Li W., Huang D., Chiang C.E., Lau C.P., Tse H.F., Chan E.W., Wong I.C.K., Lip G., Chan P.H.M. and Siu D.C.W., Efficacy and Safety of Dabigatran, Rivaroxaban and Warfarin for Stroke Prevention in patients with Atrial Fibrillation: The Hong Kong Atrial Fibrillation Project, Clin Cardiol. 2017, 40(4): 222-229.
Man K.C.K., Li X., Chan E.W. and Wong I.C.K., The Long term use of biologics in Hong Kong., ICPE, Dublin, Ireland, 25-28th August. 2016.
SING C.W., Wong I.C.K., Cheung B.M.Y., Chan C.Y.J., Chu K.P.J. and Cheung C.L., Incidence and risk estimate of drug-induced agranulocytosis in Hong Kong Chinese. A population-based case-control study, Pharmacoepidemiology and Drug Safety. 2017, 26: 248-255.
WONG Y.S., Chan E.W., Anand S., Worsley A.J. and Wong I.C.K., Managing cardiovascular risk of macrolides: systematic review and meta-analysis. , Drug Saf . 2017.
WONG Y.S., Wong I.C.K., CHUI S.L.C., LEE E.H.M., CHANG W.C., CHEN E.Y.H., LEUNG W.K. and Chan E.W., Neuropsychiatric Events Associated with the Use of Helicobacter Pylori Eradication Therapy Containing-Clarithromycin: Self-Controlled Case Series, 32nd ICPE, Dublin, August 26-28, 2016.


Researcher : Wong KC

List of Research Outputs

LAM C.S., Tipoe G.L., Wong K.C., Youdim M.B.H. and Fung M.L., M30 Antagonizes Indoleamine 2,3-Dioxygenase Activation and Neurodegeneration Induced by Corticosterone in the Hippocampus, In: Kenji Hashimoto, Chiba Daigaku, PLoS ONE. 2016.


Researcher : Wong YS

List of Research Outputs

CHUI S.L.C., WONG Y.S., Lee H.M.E., Chang W.C., Chen E.Y.H., Wong I.C.K. and Chan E.W., Potential association between the use of oral fluoroquinolones and acute neuropsychiatric disorders in Hong Kong: a self-controlled case series study., ICPE, Dublin, Ireland, 25-28th August . 2016.
CHUI S.L.C., Wong I.C.K., WONG Y.S., LEE E.H.M., CHANG W.C., CHEN E.Y.H. and Chan E.W., The Association Between the Use of Oral Fluoroquinolones and Neuropsychiatric Events: A Self-Controlled Case Series Study, 32nd ICPE, Dublin, August 25-28, 2016.
Leung W.K., Chan E.W., Wong Y.S., Chen L., Wong O.L., Wong I.C. and Cheung M.K.S., Age of Helicobacter pylori Eradication and Subsequent Risk of Gastric Cancer Development: A Population-Based Study, Digestive Disease Week, 6-9 May 2017, Chicago, USA. 2017.
WONG Y.S., Chan E.W., Anand S., Worsley A.J. and Wong I.C.K., Managing cardiovascular risk of macrolides: systematic review and meta-analysis. , Drug Saf . 2017.
WONG Y.S., Wong I.C.K., CHUI S.L.C., LEE E.H.M., CHANG W.C., CHEN E.Y.H., LEUNG W.K. and Chan E.W., Neuropsychiatric Events Associated with the Use of Helicobacter Pylori Eradication Therapy Containing-Clarithromycin: Self-Controlled Case Series, 32nd ICPE, Dublin, August 26-28, 2016.


Researcher : Woo WHC

Project Title:Role of gut microbiota and prebiotics on glucose metabolism during pregnancy
Investigator(s):Woo WHC
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:06/2015


Project Title:Maternal Lipid Trafficking mediated by Gut Microbiota and TLR5
Investigator(s):Woo WHC
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:06/2016


Project Title:Keystone Symposium: Integrating Metabolism and Immunity ; Anticipation of toll-like receptor 5 in atherosclerosis via regulation of lipoproteins
Investigator(s):Woo WHC
Department:Pharmacology & Pharmacy
Source(s) of Funding:URC/CRCG - Conference Support for Teaching Staff
Start Date:05/2017
Completion Date:06/2017


Project Title:Anticipation of Gut Microbiota in Atheroprotection via TLR5 signaling
Investigator(s):Woo WHC
Department:Pharmacology & Pharmacy
Source(s) of Funding:Seed Fund for Basic Research
Start Date:06/2017


List of Research Outputs

CHEN J. and Woo W.H.C., Metabolic Function of TIR-Domain-containing Adaptor-inducing Interferon-b (TRIF) in Diet-induced obesity, The University of Hong Kong. 2016.
CHEN J., LI J., Xu A. and Woo W.H.C., Metabolic Function of TIR-Domain-containing adapter-inducing interferon-b (TRIF) in hepatocytes, In: Federation of American Societies for Experimental Biology, FASEB Science Research Conference: Immunological Aspects of Obesity. 2016.
CHEN J., Li J., Xu A. and Woo W.H.C., Metabolic function of TIR-domain-containing adapter-inducing interferon-b (TRIF) in hepatocytes, FASEB Science Research Conferences, July 31- August 5, 2016, Big Sky, Montana. 2016.
GENG L., LIAO B., JIN L., HUANG Z., Woo W.H.C., Lam K.S.L. and Xu A., Chronic exercise alleviated dietary obesity-associated metabolic dysfunction by enhancing FGF-21 sensitivity in adipose tissues., The 99th Annual Meeting of the American Endocrine Society, 1-4 April 2017, Orlando, USA. 2017.
Li J. and Woo W.H.C., Finding ways to solve or prevent aminoglycoside-induced ototoxicity?, Annals of Translational Medicine. 2016, 4: 533-533.
Shang Y., Khafipour E., Derakhshani H., Sarna L.K., Woo W.H.C., Siow Y.L. and O K., Short Term High Fat Diet Induces Obesity-Enhancing Changes in Mouse Gut Microbiota That are Partially Reversed by Cessation of the High Fat Diet., Lipids. Springer, 2017, 52: 499-511.
YIU J.H.C., Dorweiler B. and Woo W.H.C., Interaction between Gut Microbiota and Toll-like Receptor: from Immunity to Metabolism, Journal of Molecular Medicine. 2016.
YIU J.H.C. and Woo W.H.C., The Commensal role of Gut microbiota in Pregnancy via Toll-like receptor 5, The University of Hong Kong. 2017.
Yiu J.H.C., Xu A. and Woo W.H.C., Anticipation of toll-like receptor 5 in atherosclerosis via regulation of lipoproteins, Keystone Symposium: Integrating Metabolism and Immunity, Dublin, 29May-2Jun, 2017.


Researcher : Worsley AJ

List of Research Outputs

WONG Y.S., Chan E.W., Anand S., Worsley A.J. and Wong I.C.K., Managing cardiovascular risk of macrolides: systematic review and meta-analysis. , Drug Saf . 2017.


Researcher : XU Y

List of Research Outputs

XU Y., Liang W., Qiu Y., Cespi M., Palmieri G.F., Mason A.J. and Lam J.K.W., Incorporation of a nuclear localization signal in pH responsive LAH4-L1 peptide enhances transfection and nuclear uptake of plasmid DNA, Molecular Pharmaceutics. 2016, 13: 3141-3152.


Researcher : Xu C

Project Title:Selective overexpression of SIRT1 in adipose tissue protects adiponectin deficiency induced liver injury
Investigator(s):Xu C, Wang Y
Department:Pharmacology & Pharmacy
Source(s) of Funding:Health and Medical Research Fund - Full Grant
Start Date:04/2017


List of Research Outputs

Sun W.Y., Yang K., Luo C., Feletou M., Villeneuve N., Vanhoutte P.M.G.R., Xu C. and Wang Y., Role of lipocalin-2 in dietary and aldosterone-induced renal damages, Experimental Biology 2017. The FASEB, 31: Suppl 998.10.


Researcher : YANG K

List of Research Outputs

Sun W.Y., Yang K., Luo C., Feletou M., Villeneuve N., Vanhoutte P.M.G.R., Xu C. and Wang Y., Role of lipocalin-2 in dietary and aldosterone-induced renal damages, Experimental Biology 2017. The FASEB, 31: Suppl 998.10.
Sun W.Y., Yang K., Luo C., Feletou M., Villeneuve N., Vanhoutte P.M.G.R., Xu A. and Wang Y., Role of lipocalin-2 in dietary and aldosterone-induced renal damages, Experimental Biology 2017. The FASEB, 31.
YANG K., Deng H., MAN W.C., SONG E., Zhang J., Luo C., Cheung B.M.Y., Yuen K.Y., Jensen P.S., Irmukhamedov A., Elie A...G...I...M., Vanhoutte P.M.G.R., Xu A., De Mey J.G.R. and Wang Y., Measuring non-polyaminated lipocalin-2 for cardiometabolic risk assessment, ESC Heart Failure. 2017, 1-13.
YANG K., Role of Lipocalin-2 Deficiency in Cardio-renal Damages, 21st Research Postgraduate Symposium, December 1-2, 2016, Hong Kong. 2016.


Researcher : YING F

List of Research Outputs

YING F. and Tang E.H.C., Deficiency of Prostaglandin E Receptor Subtype 4 (EP4) Favored Multilocular Fat Cell Formation and Increased Mitochondrial Biogenesis through the AMPK-FSP27 Axis, 12th International Symposium on Healthy Aging, 11-12 March 2017, Hong Kong. 2017.
YING F., Cai Y., Wong H.K., Lee T. and Tang E.H.C., Disturbed cholesterol homeostasis in prostaglandin E receptor 4 knockout mice model, The 6th ICCR Congress on Chronic societal Cardiometabolic Diseases. 2017.
YING F., Cai Y. and Tang E.H.C., Prostaglandin E receptor subtype 4 (EP4) regulates lipid droplet size and mitochondrial activity via FSP27 in white adipose tissue, Metabolic Diseases; Breakthrough Discoveries in Diabetes & Obesity, Novotel Melbourne St Kilda, 1-2 December 2016.
YING F., Cai Y., CAI Y., Wang Y. and Tang E.H.C., Prostaglandin E receptor subtype 4 regulates lipid droplet size and mitochondrial activity in murine subcutaneous white adipose tissue, The FASEB Journal. 2017, 331: 4023-4036.
YING F., Cai Y. and Tang E.H.C., Prostaglandin receptor subtype 4 (EP4) deficiency enhanced multilocular fat cell formation and mitochondrial biogenesis and facilated wat remodeling, The 6th ICCR Congress on Chronic Societal Cardiometabolic Diseases, May 15-17, 2017, Quebec Canada. 2017.


Researcher : YIU JHC

List of Research Outputs

YIU J.H.C., Dorweiler B. and Woo W.H.C., Interaction between Gut Microbiota and Toll-like Receptor: from Immunity to Metabolism, Journal of Molecular Medicine. 2016.
YIU J.H.C. and Woo W.H.C., The Commensal role of Gut microbiota in Pregnancy via Toll-like receptor 5, The University of Hong Kong. 2017.
Yiu J.H.C., Xu A. and Woo W.H.C., Anticipation of toll-like receptor 5 in atherosclerosis via regulation of lipoproteins, Keystone Symposium: Integrating Metabolism and Immunity, Dublin, 29May-2Jun, 2017.


Researcher : Yang K

List of Research Outputs

Sun W.Y., Yang K., Luo C., Feletou M., Villeneuve N., Vanhoutte P.M.G.R., Xu C. and Wang Y., Role of lipocalin-2 in dietary and aldosterone-induced renal damages, Experimental Biology 2017. The FASEB, 31: Suppl 998.10.
Sun W.Y., Yang K., Luo C., Feletou M., Villeneuve N., Vanhoutte P.M.G.R., Xu A. and Wang Y., Role of lipocalin-2 in dietary and aldosterone-induced renal damages, Experimental Biology 2017. The FASEB, 31.
YANG K., Deng H., MAN W.C., SONG E., Zhang J., Luo C., Cheung B.M.Y., Yuen K.Y., Jensen P.S., Irmukhamedov A., Elie A...G...I...M., Vanhoutte P.M.G.R., Xu A., De Mey J.G.R. and Wang Y., Measuring non-polyaminated lipocalin-2 for cardiometabolic risk assessment, ESC Heart Failure. 2017, 1-13.
YANG K., Role of Lipocalin-2 Deficiency in Cardio-renal Damages, 21st Research Postgraduate Symposium, December 1-2, 2016, Hong Kong. 2016.


Researcher : Ye D

Project Title:Lipocalin-2 in acute and chronic liver diseases: focusing on neutrophil-mediated innate immune responses
Investigator(s):Ye D, Wang Y, Wong ICK
Department:Pharmacology & Pharmacy
Source(s) of Funding:Health and Medical Research Fund - Full Grant
Start Date:10/2013
Completion Date:05/2017


Project Title:Gut Microbiota Modulation of Host Physiology: The Search for Mechanism (C1); Neutrophil-derived Lipocalin-2 Mediates Nonalcoholic Steatohepatitis through Modulating Crosstalk between Mucosa Immunity and Gut Microbiota
Investigator(s):Ye D
Department:Medicine
Source(s) of Funding:URC/CRCG - Conference Support for Teaching Staff
Start Date:03/2015




Researcher : ZHANG P

List of Research Outputs

ZHANG P., Effects of Genistein on Cigarette Smoke-induced inflammatory Responses in Human Bronchial Epithelial BEAS-2B Cells and in Rats, 21st Research Postgraduate Symposium, December 1-2, 2016, Hong Kong. 2016.
ZHANG P., Mak J.C.W., Man R.Y.K. and Leung S.W.S., Effects of genistein on inflammatory responses in cigarette smoke-exposed rats, Pharmacology 2016, The Queen Elizabeth II Conference Centre, London, 13-15 December, 2016.


-- End of Listing --